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ABSTRACT 
Previous researchers have demonstrated that Autism Spectrum Disorder (ASD) is related 
to increased prevalence of other psychological disorders.  Comorbid disorders increase the 
difficulties in socialization and communication already experienced by children with ASD.  
These symptoms often require additional intervention techniques and should be identified as 
early as possible to beget the best prognosis.  The Autism Spectrum Disorders – Child Version 
(ASD-C) is an informant based assessment battery specifically designed to measure symptoms of 
ASD, comorbid disorders, and challenging behavior in children with ASD.  The reliability and 
validity of this assessment has been established in previous studies, but there is no research to 
date that compares the measure to the Child Behavior Checklist (CBCL) to establish construct 
validity of both measures.  Participants in the current study included 114 children classified into 
three categories: ASD (n=14), psychopathology (n=71), and controls (n=29).  Parents completed 
the ASD-C and CBCL as part of comprehensive psychological evaluations.  Following a content 
analysis assessing correlations between items on the two measures, a Multitrait-Multimethod 
Matrix was constructed to assess convergent and divergent validity.  All subscales and 
composites from both measures demonstrated convergence.  Additionally, receiving operator 
characteristic (ROC) curves were utilized to examine the diagnostic validity of the two measures 
for ASD, Anxiety Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD), and Oppositional 
Defiant Disorder (ODD).  Both measures demonstrated diagnostic utility for clinicians to screen 
for psychopathology in children with and without ASD.  Time and cost effective parent report 
measures would fill a gap in the provision of mental health services to low SES children and 
their families.           
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CHAPTER 1. INTRODUCTION 
1.1 Early Definitions of Autism 
 The disorder that we conceptualize as Autism Spectrum Disorder (ASD) today has 
undergone numerous modifications from its original form.  Leo Kanner (1943) is credited with 
being the first psychiatrist to provide a detailed description of the childhood disorder that he 
labeled autistic disturbances of affective contact or autism.  In his seminal paper, Kanner (1943) 
provided a detailed case study of 11 children who demonstrated disturbances in social interaction 
and communication (e.g., muteness, echolalia, or nonfunctional speech).  Additionally, these 
children exhibited repetitive or ritualistic patterns of behavior, restricted interests in specific 
objects or parts of objects, and insistence on sameness in their environment.  Kanner’s use of the 
term autism was meant to reflect the self-centered, isolating quality of these children (Volkmar 
& Klin, 2005).  He described these children as demonstrating evidence of these impairments 
since birth, and thus, the disorder was likely biological in origin.  Kanner revised his initial 
observations to highlight the importance of self-isolation and insistence on sameness when 
distinguishing autism from other childhood disorders (Eisenberg & Kanner, 1956).  Moreover, 
Kanner proposed that these autistic symptoms must be evident prior to 2 years of age.   
Much of Kanner’s (1943) initial conceptualization of autism is still considered to be 
central to the disorder as we know it today.  For example, impairments in socialization, 
communication, and restricted, repetitive behaviors or interests (RRBIs) are still the core 
symptoms.  However, Kanner’s paper proposed that individuals with autism were not 
intellectually disabled, but rather, these children tended to demonstrate poor performance on 
intelligence tests, especially verbal tasks, and in everyday activities due to a lack of motivation.  
In subsequent decades, researchers had provided evidence that as many as 75% of children with 
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autistic disorder (i.e., those with the most severe form of ASD) do actually have an intellectual 
disability (ID; i.e., IQ below 70; Lockyer & Rutter, 1970; Matson & Nebel-Schwalm, 2007a; 
Rutter, 1968).   
 Other early misconceptions about autism have also been dispelled by researchers, 
although they can make it difficult to accurately track research findings in the literature.  In 
particular, early researchers often referred to the disorder as childhood schizophrenia, a term that 
was utilized until the 1970s (Rutter, 1978).  This confusion originated from Kanner’s (1943) use 
of the term autism, which had previously been coined by Bleuler, a Swiss psychiatrist, to 
describe the disconnection from external reality and social isolation displayed by people with 
schizophrenia (Bleuler, 1913).  The seeming overlaps between the two disorders and the poor 
prognoses for those with autism and those with schizophrenia led many in the field to 
conceptualize autism as an early form of schizophrenia (Bender, 1946).  In 1961, Creak provided 
a diagnostic outline of a disorder he referred to as early childhood psychosis that overlapped with 
the diagnostic criteria for autism.  Early childhood psychosis was characterized by nine main 
symptoms: 1) impairments in interpersonal relationships (e.g., social isolation); 2) regression in 
speech, complete failure to acquire language, or abnormal speech (e.g., echolalia, pronoun 
reversal, speaking in monotone); 3) unawareness of personal identity (e.g., self-injurious 
behavior, failure to use personal pronouns, and abnormal body postures); 4) preoccupation with 
parts of objects as opposed to the intended function of the object; 5) abnormal perceptual 
experiences and responses to environmental stimuli (e.g., hyper- or hypo-sensitivity to pain or 
noises); 6) insistence on sameness; 7)  intellectual disability, (although this was not true of all 
children with the disorder); 8) excessive anxiety and resistance to environmental change; and 9) 
abnormal motor movements (e.g., abnormal gait, poor coordination, repetitive movements).  
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Unfortunately, Creak did not specify how these behavior patterns were unique and separate from 
autism, and thus, some of these symptoms (i.e., abnormal sensory experiences) have been 
incorporated into assessment measures for autism over the years despite lack of support from 
scientific research (Matson & Minshawi, 2006). 
As late as 1977, the International Classification of Diseases, Ninth Edition (ICD-9; 
WHO, 1977) still grouped autism with the childhood psychotic disorders, despite scientific 
research that clearly delineated the differences between autism and schizophrenia.  Of note, the 
two disorders are inconsistent in terms of language and cognitive development, which are normal 
in those with schizophrenia and atypical in those with autism (Kolvin, 1971; Rutter & Bartak, 
1971).  Additionally, the experience of hallucinations or delusions is only present in those with 
schizophrenia and not a characteristic of autism (Kolvin, 1971).  The two disorders differ in 
terms of distribution between the two genders, with autism more common in males and no 
gender difference observed in the rate of schizophrenia (Rutter & Bartak, 1971).  Of most 
importance in terms of diagnosis is the differing ages of onset, with ASD apparent much earlier 
than schizophrenia.  To highlight this difference, Rutter and Bartak (1971) added onset of 
symptoms prior to 30 months of age to Kanner’s (1943) original three criteria for autism.   
More than 20 years after Kanner’s seminal paper, the research of Michael Rutter and 
Edward Ritvo, chairman of The National Society for Autistic Children (NSAC), served to clarify 
the core symptoms of autism and allow for more widespread diagnosis by physicians and 
psychologists (Schopler, 1978).  Despite this push for clarity, the two men proposed separate and 
not completely compatible definitions.  Rutter largely advocated a return to Kanner’s initial 
definition of autism with the caveat that the scientific community should empirically test these 
hypotheses (Rutter, 1978).  His conceptualization grouped autistic symptoms into three broad 
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categories: 1) impairment in socialization leading to a failure to develop relationships that are 
developmentally appropriate; 2) impairment in communication (delayed or impaired language 
development, idiosyncratic speech, impaired nonverbal communication); and 3) RRBIs.    
Conversely, Ritvo (1978) and the NSAC consensus provided the following core features 
of autism: 1) disturbances in the ability to relate to people, objects, and environmental stimuli; 2) 
disturbances in language and communication abilities; 3) abnormal development (i.e., motor, 
adaptive, cognitive); and 4) disturbances in responses to sensory experiences.  Both Rutter 
(1978) and Ritvo (1978) proposed that these features must be present prior to 30 months of age.  
They noted that intellectual impairment, epilepsy, and self-injurious behaviors were commonly 
co-occurring conditions.  The NSAC description also included mood lability (e.g., unexpected 
crying or laughing) and inappropriate fears.  While, Rutter (1978) specified that children with 
autism often exhibit a shortened attention span and delayed bowel control, although these are not 
characteristic of all children with autism.  He made the suggestion that clinicians take into 
account mental age (i.e., intellectual level) and presence of neurological disorders when 
assessing behaviors, because this may impact judgments of developmental appropriateness.    
 The definitions put forth by Rutter (1978) and Ritvo (1978) are largely consistent in their 
descriptions of the three core features of autism.  However, the process behind their 
conceptualization and even their motivating factors are divergent.  Rutter’s definition developed 
out of the historical perspective dating back to Kanner (1943) and took into account recent 
scientific findings.  Whereas Ritvo’s definition was motivated by a desire to increase public 
awareness and incite political action to fund treatments and research for autism (Matson & 
Minshawi, 2006).  Despite their differences, these two definitions have contributed greatly to 
advances in research and the development of empirically supported treatments for autism.  
 5 
 
Critical to past and current definitions of autism is the criterion for impairment in social 
interaction, which is evident from infancy.  Children with autism frequently lack affection, 
cuddling, or emotional attachment to their caregivers.  They are often described by their 
caregivers as self-isolating and will not seek out their parent to be comforted when they are in 
pain or upset.  These children regularly fail to develop social-communicative behaviors (e.g., 
holding arms up when they want to be held, eye-to-eye gaze).  Moreover, children with autism 
may experience stranger anxiety, fail to make eye contact, and seem uninterested or unwilling to 
participate in simple interaction games (e.g., peek-a-boo).  As the children grow older, other 
social impairments become evident in terms of failure to make friends, lack of empathy, and 
inability to engage in cooperative play. These deficits in socialization and communication can 
lead to the child engaging in socially inappropriate speech or actions towards others (Rutter, 
1978).  Children with autism often appear immature and have difficulty understanding social 
cues (i.e., turn taking, signs of disinterest).   
The second key component of autism is impairment in communication.  Children with 
autism typically have delayed language acquisition or fail to develop any functional language.  
Paralleling the socialization deficits, this abnormality is present from infancy, as children with 
autism often fail to develop pre-language skills (e.g., social imitation, reciprocal smiling, and 
joint attention).  Additionally, children with autism are frequently impaired in their use of 
gestures to communicate their wants and needs.  Even when language does begin to develop, it 
may be echolalia, include pronoun reversals, involve abnormal inflection, or a singsong rhythm.  
These children may have a limited capacity to understand abstract terms, concepts, or reasoning.  
Likewise, a number of children with the most severe form of autism never develop functional 
speech (Rutter, 1978).  
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RRBIs comprise the third component of autism.  Children may exhibit rigid or ritualistic 
play patterns that lack imagination and flexibility.  Examples of such behavior include lining up 
toys, collecting objects, compulsive touching, or playing with only parts of a toy (Rutter, 1978).  
Often, these children will engage in tantrums or other challenging behavior if the toy or object is 
removed.  Another common RRBI is insistence on sameness, to the extent that the child will 
exhibit extreme distress if routines or stimuli in the environment are altered.  Children with 
autism also exhibit stereotyped repetitive behaviors (e.g., spinning, hand-flapping, body rocking, 
touching) at higher rates than individuals with ID, although the behavior is common to children 
with autism and those with ID (Bodfish, Symons, Parker, & Lewis, 2000).   
Aside from these three primary categories of disturbances in children with autism, there 
are other abnormalities in development and perceptual experiences that commonly occur in 
children with autism.  These disturbances often involve delayed or impaired development of 
adaptive skills.  One common area of associated adaptive impairment involves atypical motor 
movements (e.g., motor apraxia, gross motor delay, toe-walking) that impact functioning (Ming, 
Brimacombe, & Wagner, 2007).  For example, a child with autism may exhibit typical gross 
motor development, but experience difficulties with tasks requiring fine motor skills.  On the 
other hand, a child with autism may exhibit normal development until a certain age and then 
experience cessation or regression of skills.  For example, a child may begin talking within 
normal limits, but then experience a regression in language skills or even a complete loss of 
functional speech.  Conversely, a child may be delayed in the development of language and then 
rapidly acquire a large number of communication skills (Ritvo, 1978).  
Another associated symptom of autism is abnormal responsiveness to sensory stimuli 
(Klintwall et al., 2011).  This can involve abnormal auditory responses (i.e., hyper- or hypo-
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sensitivity to sounds or non-responsiveness to certain sounds); tactile sensations (i.e., hypo- or 
hyper-sensitivity to pain, temperature, and certain textures of clothing); vestibular experiences 
(i.e., self-spinning without dizziness or preoccupation with spinning objects); olfactory and 
gustatory sensations (i.e., sniffing and/or licking people or objects and food preferences 
involving specific textures); proprioceptive senses (i.e., body postures, hand flapping, 
grimacing); and visual disturbances (i.e., poor eye-contact, staring at objects, sensitivity to light, 
or paying attention to parts of objects instead of the whole).  Additionally, children with autism 
may exhibit abnormal activity levels (i.e., hyperactivity or psychomotor retardation), which can 
fluctuate over the lifespan (Zwaigenbaum, Bryson, Rogers, Roberts, Brian, & Szatmari, 2005). 
1.2 Evolution of the Current Definition of ASD 
The earliest prevalence estimates were established by Wing and Gould (1979), who 
conducted an epidemiological study of autism based on Kanner’s (1943) early definition and 
more recent revisions.  They surveyed the caregivers of one hundred thirty-two children who 
exhibited one or more of the three core symptoms (i.e., impaired socialization, abnormal 
language development and/or communication deficits, and RRBIs) and/or met criteria for an ID 
(as measured by a standardized intelligence test).  They analyzed general rates of impairment, 
how these symptoms were related to presence or absence of ID, and how the symptoms could be 
categorized.  Caregivers completed structured interviews about the children’s symptoms, while 
the children’s behaviors were rated by trained observers.  Wing and Gould (1979) found that the 
nature of the children’s ability to interact (i.e., sociable, aloof, passive but odd) could reliably 
discriminate between a “socially impaired” group and a “sociable severely mentally retarded” 
group.  Additionally, all the children in the “socially impaired” group exhibited repetitive 
behaviors and most lacked functional language.   
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There was a significant positive correlation between severity of ID and being classified as 
“socially impaired.”  However, idiosyncratic use of language, elaborate routines, and pronoun 
reversals reliably distinguished children with autism from children with ID (Wing and Gould, 
1979).  Notably, only 17 of the 74 children in the “socially impaired” group met criteria for 
autism based on Kanner’s definition.  Thus, Wing and Gould (1979) suggested that the definition 
of autism be broadened to encompass a larger number of impairments in social interaction.  They 
proposed a triad of deficits that became a hallmark of research about autism.  These deficits 
included: impairments in social interaction; impairments or complete absence of language and 
communication; and impairment in flexibility and imagination (i.e., insistence on sameness and 
presence of repetitive and stereotyped behaviors and interests).       
These landmark research findings led to the creation of a new category of disorders that 
included autism and several other childhood disorders in the publication of the Diagnostic and 
Statistical Manual of Mental Disorders, 3
rd
 Edition (DSM-III; American Psychiatric Association 
[APA], 1980).  The title Pervasive Developmental Disorders (PDDs) was given to the chapter 
that encompassed infantile autism (i.e., Rutter’s 1978 definition), residual infantile autism, 
childhood onset pervasive developmental disorder (COPDD), and atypical pervasive 
developmental disorder.  Residual infantile autism was a diagnosis meant to encapsulate children 
who no longer met criteria for autism, but still required services.  COPDD was the diagnosis that 
accounted for children who developed autism symptoms after 30 months of age, but was 
considered to be extremely rare (Burd, Fisher, & Kerbeshian, 1988).  Atypical pervasive 
developmental disorder was the original version of pervasive developmental disorder not 
otherwise specified, and was a diagnosis to account for individuals who met some of the criteria 
for autism, but did not cross the diagnostic threshold for a specific PDD.  Overall, the category of 
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PDDs was utilized to diagnose children and adults who met some or all of the diagnostic criteria 
outlined by Rutter (1978) and explicitly excluded those with hallucinations and delusions 
solidifying the split between autism and childhood schizophrenia.   
As with all diagnostic manuals, the DSM is constantly under scrutiny in response to new 
research findings and new assessment tools.  Thus, revisions to the DSM-III began not long after 
its publication (Volkmar & Klin, 2005).  Revisions to the definition of autism and the broader 
PDD category were largely influenced by Wing and Gould’s (1979) triad of impairment.  The 
most prominent and enduring change in the DSM-III-R (APA, 1987) was to use the term Autistic 
Disorder instead of infantile autism.  This revision was made to highlight that autism is not 
merely a disorder of childhood and results in lifelong impairments (Volkmar, Cohen, & Paul, 
1986).  The revision also removed the age of onset, effectively eliminating the COPDD 
diagnosis.  Unfortunately, this also led to over diagnosis of autism in many cases, and the false-
positive rate was increased by approximately 40% (Spitzer & Siegel, 1990).  The decision to 
remove age of onset was inconsistent with empirical evidence and made it more difficult to 
conduct longitudinal research.  Additionally, the DSM-III-R definition of autism was inconsistent 
with the definition in the ICD, which was more stringent (Volkmar & Klin, 2005).  
In response to this inconsistency, the development of the DSM-IV (APA, 1994) focused 
on more closely matching diagnostic criteria with the soon to be published ICD-10 (WHO, 
1992).  The revisions to the PDD diagnoses in the DSM-IV focused on increasing reliability and 
validity, as well as making the criteria more easily understood by clinicians (Volkmar et al., 
1994).  A comprehensive field trial was conducted to evaluate the new diagnostic criteria and 
reduce the number of false-positives.  Twenty-one sites and 125 raters across multiple countries 
participated in the study.  In total, 977 individuals were categorized according to the proposed 
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criteria for Autistic Disorder, Asperger’s Disorder, Childhood Disintegrative Disorder (CDD), 
and Rett’s Disorder.  The authors concluded that the new diagnostic criteria was reliable and 
demonstrated sufficient convergent validity with the ICD-10 criteria (Volkmar & Klin, 2005).   
The field trial also revealed that age of onset of symptoms was positively correlated with 
IQ.  This is in accordance with findings that individuals with Asperger’s Disorder, who tended to 
have higher IQs than those with Autistic Disorder, were diagnosed at the average age of 7.2 
years (Mandell, Novak, & Zubritsky, 2005).  The decision to include broader categories (e.g., 
Asperger’s Disorder, Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS), 
CDD, and Rett’s Disorder) helped account for the presence of autism symptoms across the life 
span.  Additionally, by increasing the age of onset criteria to 36 months of age for Autistic 
Disorder, the sensitivity of the diagnosis was increased.  The reliability of the criteria was also 
increased when more experienced raters made the diagnoses (Klin, Lang, Cicchetti, & Volkmar, 
2000).  Despite the increased reliability and stability of diagnoses in the short-term (i.e., under a 
year), the criteria were still unstable among toddlers with lower levels of intellectual and 
adaptive functioning (Volkmar & Klin, 2005).  Volkmar and colleagues (1994) found that 
placing more emphasis on socialization deficits increased sensitivity.  This shift in diagnostic 
emphasis was also consistent with Kanner’s definition of autism, which categorized social 
impairments as the primary deficit (Volkmar & Klin, 2005).  
The DSM-IV introduced broader categories that conceptualized autism symptoms as 
occurring across a spectrum of disorders.  Wing (1988) proposed that autistic symptoms and the 
associated disorders may be better understood as a continuum, or spectrum, of disorders.  
Conceptualizing autism as a spectrum of disorders was supported by developmental research 
demonstrating that there are not clearly defined boundaries between classical autism and the 
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related disorders (Dahl, Cohen, & Provence, 1986; Waterhouse et al., 1996; Waterhouse, Wing, 
& Fein, 1989; Wing, 1988).  Although the different diagnostic categories are now subsumed 
under the heading Autism Spectrum Disorder, the history of Asperger’s Disorder, PDD-NOS, 
CDD, and Rett’s Disorder will now be reviewed in subsequent sections to highlight the 
heterogeneity of individuals with ASD.   
1.2.1 Asperger’s Disorder 
 Unbeknownst to Kanner, Hans Asperger, an Austrian physician, published a case study 
of 4 children with similar impairments in socialization and communication.  Asperger (1944) 
termed the disorder autistic psychopathology and identified six main symptoms: 1) impairments 
in verbal communication, 2) impairments in nonverbal communication, 3) difficulties with 
socialization and specific interests that were abnormal in intensity, 4) motor clumsiness and odd 
body postures, 5) conduct problems, and 6) intellectualization (i.e., suppression of affective 
response).  
These children differed in important ways from the children described by Kanner (1943).  
For example, Asperger (1944) described children who had developed functional language, but 
whom often spoke in an odd, incoherent, or tangential manner.  Other common characteristics 
were the tendency not to modulate volume when speaking and/or singsong speech.  Additionally, 
the children appeared unaware of social cues and tended to have one-sided conversations focused 
on a topic of interest to them.  When speaking about these topics, the children would often sound 
pedantic leading to difficulties making friends.  Their singular focus would consume large 
amounts of time and lead to the neglect of self-care, further hindering social interaction.  Another 
interesting characteristic of the children Asperger identified was their superior rote memory of 
factual knowledge (e.g., bus schedules, historical dates, mathematical equations).  These children 
 12 
 
were able to recite facts that were beyond their educational level, although they often could not 
utilize these facts in a meaningful way. 
The socialization deficits that were central to Kanner’s (1943) definition of autism were 
also present in the children identified by Asperger, although the specific deficits differed. 
Asperger described children who could communicate at a basic level, but struggled to understand 
other’s emotions or idiosyncratic use of language.  These children would intellectualize their 
affect, meaning they would turn to facts and logic when confronted with uncomfortable feelings 
(Volkmar, 2011).   In social situations, where the children were unable to isolate themselves 
from these emotions, these children had a tendency to evince challenging behaviors including 
physical aggression (Bjorkly, 2009; Ghaziuddin, Tsai, Ghaziuddin, 1991; Katz & Zemishlany, 
2006; Simpson & Myles, 1998).  These children also seemed to have the associated 
characteristics of clumsiness, odd posture, abnormal gait, and poor handwriting (Green, Baird, 
Barnett, Henderson, Huber, & Henderson, 2002).  These abnormalities in motor skills combined 
with their circumscribed interests resulted in these children being bullied by their peers at higher 
rates than typical children (Sofronoff, Dark, & Stone, 2011).   
Asperger published his original findings in German, and it was not until 1991 that an 
English translation of his work was available to a wide-spread audience (Frith, 1991).  In the 
meantime, Van Krevelen (1971) endeavored to delineate the differences between the disorder 
described by Kanner (1943) and the one described by Asperger (1944).  He proposed that the 
two disorders, while similar, were distinct.  Early infantile autism, as described by Kanner, was 
characterized by the following: evident from infancy, involves delayed language development 
and language is often nonfunctional when it does develop, lack of eye contact, and social 
withdrawal.  Whereas autistic psychopathology, as described by Asperger, was characterized by 
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the following: manifests after age 3 years, involves delays in motor functioning, normal language 
development, and the individual’s desire to interact with others.  Krevelen referred to autism as 
“a psychotic process” and Asperger’s Disorder as “a personality trait.”  Overall, children who 
were best characterized by Asperger’s description had a better prognosis than the children who 
fit Kanner’s definition.   
The debate about whether to classify Asperger’s Disorder as a form of autism or a 
distinct disorder continues until the present day.  In 1981, Wing clarified the core features of 
Asperger’s Disorder and described the syndrome as falling into a larger group of disorders that 
was characterized by impairments in social interaction, communication, and imagination.  She 
suggested some modifications and additions to the current diagnostic criteria for Asperger’s 
Disorder.  For example, Wing (1981) noted that as many as half of children with Asperger’s 
Disorder had some delays in speech acquisition.  Although they eventually obtained functional 
language skills, these children still struggled with pragmatics and relating to same-aged peers.  
Additionally, Wing (1981) pointed out that children with Asperger’s Disorder often lacked 
pretend play as young children, and as adults they were best described as pedantic, literal, and 
logical instead of creative.   
Wing’s (1981) account of Asperger’s Disorder also highlighted some of the main 
differences between Asperger’s Disorder and autism.  The take home message was that autism 
involved more severe impairments in socialization and communication than Asperger’s Disorder.  
While children with autism were “aloof and indifferent,” children with Asperger’s Disorder were 
“passive or inappropriate” towards others.  Children with autism appeared uninterested in social 
interaction, whereas children with Asperger’s Disorder tried to socialize, but often experienced 
rejection or bullying.  As for communication deficits, children with autism often failed to 
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develop functional language, whereas children with Asperger’s Disorder tended to develop 
appropriate grammar and vocabulary, but struggled with comprehension and enriched content.  
Additionally, while both groups of children were described as having restricted interests, 
children with autism tended to exhibit repetitive behaviors, insistence on sameness, 
preoccupation with parts of objects, and rituals.  On the other hand, children with Asperger’s 
Disorder tended to have circumscribed interests in specific topics or activities.   
The DSM-IV-TR and ICD-10 were criticized for not accurately distinguishing between 
children with high-functioning autism (HFA) and children with Asperger’s Disorder (Freeman, 
Cronin, & Candela, 2002; Mayes, Calhoun, & Crites, 2001).  Empirical research failed to support 
the diagnostic validity of the DSM-IV-TR criteria for Asperger’s Disorder (Mayes & Calhoun, 
2004; Tryon, Mayes, Rhodes, & Waldo, 2006).  More specifically, researchers demonstrated that 
delay in speech development is not a reliable predictor of symptom severity and adaptive 
functioning in children with HFA or Asperger’s Disorder (Eisenmajer et al., 1998; Mayes & 
Calhoun, 2001).  This has led some to conclude that there was not a meaningful diagnostic 
distinction between HFA and Asperger’s Disorder (Howlin, 2003; Miller & Ozonoff, 2000; 
Ozonoff, South, & Miller, 2000). 
After decades of debate, the distinction between autism and Asperger’s Disorder became 
a moot point with the publication of the DSM-5 (APA, 2013).  The new diagnostic manual 
groups Autistic Disorder, Asperger Disorder, CDD, and PDD-NOS into one diagnosis called 
Autism Spectrum Disorder (APA, 2013; Ozonoff, 2012).  When researchers have applied the 
DSM-5 criteria to children currently diagnosed with Asperger’s Disorder according to DSM-IV-
TR they found that only 25.0% still met criteria for ASD (McPartland, Reichow, & Volkmar, 
2012).  To account for this discrepancy, children and adults previously diagnosed with 
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Asperger’s Disorder will be assigned the diagnosis of Autism Spectrum Disorder according to 
the new criteria.   
1.2.2 Childhood Disintegrative Disorder (CDD) 
 Theodore Heller, an Austrian educator, was the first to describe children with the 
regression in skills that are characteristic of CDD (Heller, 1908).  Heller described six children 
who were typically developing until around age 3 or 4 when they exhibited a drastic regression 
in language, social, and motor skills.  He referred to the disorder as ‘dementia infantilis’ and his 
case study predated Kanner’s (1943) description of infantile autism by 35 years.  CDD was the 
most recent terminology for this long recognized disorder, as it was referred to by other names 
prior to the publication of the DSM-IV (APA, 1994).  The symptoms described by Heller were 
initially classified as ‘disintegrative psychosis of childhood’ in the ICD-9 (WHO, 1977) and a 
subtype of dementia in the DSM-III (APA, 1980). 
Heller (1930) outlined the following criteria for CDD: 1) onset between ages 3 and 4; 2) 
progressive deterioration of intellect and behavior with loss or marked impairment of language 
abilities apparent from onset; 3) associated symptoms (e.g., fear, overactivity) and possible 
hallucinations; and 4) absence of clear organic cause or neurological dysfunction.  Children with 
CDD appeared similar to children with autism in many ways, such as impairments in 
socialization, communication deficits, and presence of RRBIs.  However, they were distinct in 
their late age of onset following a period of typical development.  These children experienced 
loss of language and deterioration in adaptive skills.  Following the regression, children with 
CDD were described as having profound mental retardation and making no further 
developmental gains (Burd et al., 1988).  These children also regularly developed odd behaviors 
including stereotypies and insistence on sameness (Malhotra & Singh, 1993). 
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CDD was an extremely rare disorder, with prevalence estimated to be 1.7 per 100,000 
(Fombonne, 2002).  Further, the disorder occurred in only one out of 175 children diagnosed 
with a PDD.  Children with CDD tended to have lower adaptive functioning than matched cases 
of autism (Mouridsen, Rich, & Isager, 1998).  This is partially attributed to the high co-
occurrence of epilepsy in children previously diagnosed with CDD (Mouridsen, 2003; Tuchman 
& Rapin, 1997).  The disorder was removed from the DSM-5 and individuals with the diagnosis 
will be subsumed into the category of Autism Spectrum Disorder according to the new criteria. 
1.2.3 Rett’s Syndrome 
Rett’s syndrome is the only former ASD that occurred almost exclusively in females 
(Comings, 1986).  The X-linked genetic disorder was first identified by Andreas Rett (1966), an 
Austrian pediatric neurologist, in a case study of 22 girls with similar characteristics.  Rett 
described these girls as engaging in repetitive hand movements (i.e., wringing and/or repeatedly 
putting hands into the mouth), dementia, communication deficits, ataxia, and hyperammonemia 
(i.e., metabolic disturbance causing excess ammonia in the blood).  The disorder was initially 
termed cerebroatrophic hyperammonemia, but this metabolic condition was not found to be 
consistently characteristic of the disorder and rather an associated feature in some individuals 
(Burd, Kemp, Knull, & Loveless, 1990).  Rett’s research received limited consideration until 
Hagberg, a Swedish pediatrician whom was unfamiliar with Rett’s findings, described similar 
symptoms among a group of 16 girls in a paper he presented to the European Federation of Child 
Neurology Societies (1980, June).  His findings led to increased research and interest in this 
disorder, which became commonly referred to as Rett’s syndrome (Van Acker, Loncola, & Van 
Acker, 2005).  
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Rett’s syndrome is not typically identified at birth, despite recent research that has 
identified a genetic etiology.  Retrospective interviews with parents revealed some early warning 
signs in infancy including: involuntary finger or hand movements and autistic-like behavior 
(Trevarthen & Daniel, 2005).  However, in most instances, the symptoms of Rett syndrome do 
not become apparent until between 6 and 18 months.  These females appeared to be developing 
normally until this age, and then experienced a regression.  This period of regression is 
characterized by deceleration in the rate of head growth (sometimes resulting in microcephaly), 
loss of purposeful use of hands, failure to meet developmental milestones (e.g., speech, motor, 
social), and jerky motor movements (Hagberg, Hanefeld, Percy, & Skjeldal, 2002).  Due to these 
physical and behavioral changes, individuals with Rett syndrome typically meet criteria for 
severe to profound intellectual disability.  Additionally, the rate of comorbid epilepsy in this 
population is estimated to be as high as 90% (Huppke, Kohler, Brockmann, Stettner, & Gartner, 
2007; Steffenburg, Hagberg, & Hagberg, 2001).  Recent estimates of prevalence indicate that the 
disorder is extremely rare, occurring at a rate of 0.65 for every 10,000 births (Hagberg, 2008).  
Of note, Hagberg (2008) reported that Rett syndrome accounts for between one-fourth and one-
third of cases of serve intellectual disability in females.        
Rett syndrome is an X-linked dominant disorder, which is typically fatal in males.  The 
disorder is due to a methyl CpG binding protein 2 (MECP2) mutation on the X chromosome.  
Females are able to survive, because they have two X chromosomes and the non-mutant 
chromosome mediates transcriptional repression during the development of the central nervous 
system (Goffin et al., 2011).  Thus, the non-mutant chromosome is expressed in some cells, 
while the mutant chromosome is expressed in other cells leading to neurodevelopmental 
abnormalities (Amir et al., 1999).  Schwartzman, Bernardino, Nishimura, Gomes, and Zatz 
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(2001) reported a case of Rett syndrome in a male with a XXY karyotype.  This chromosomal 
constitution is referred to as Kleinfelter’s syndrome, and can result in hypogonadism and reduced 
fertility.  Only a few studies have been published on Rett syndrome in males so the prevalence is 
unknown, but thought to be extremely rare (Zeev et al., 2002).  Rett syndrome was removed 
from the DSM-5, because a specific etiology was identified in 1999 and thus, the disorder no 
longer needs to be defined by behavioral symptoms (Ozonoff, 2012).  This change has been 
controversial and anxiety provoking for the families of children diagnosed with Rett syndrome as 
not all individuals presenting with these symptoms have the MECP2 mutation (Mao & Yen, 
2010). 
1.2.4 Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) 
 The term PDD-NOS was first introduced in the DSM-III-R as a sub-threshold category 
for children who failed to meet the full criteria for a developmental disorder (Towbin, 2005).  
Prior to this revision, this diagnosis was referred to as atypical autism and was considered to be a 
less severe form of autism (Buitelaar, Van der Gaag, Klin, & Volkmar, 1999).  PDD-NOS served 
as a catch-all for individuals who exhibited some deficits in socialization or communication, but 
were not as severely impaired as individuals with autism.  More specifically, the DSM-IV (APA, 
1994) defined PDD-NOS as a severe impairment in socialization, communication, or presence of 
RRBIs, that does not meet criteria for a specific PDD.  One example was late age of onset, 
because age of onset had to be prior to 36 months of age to meet criteria for autism.  The criteria 
in the DSM-IV-TR (APA, 2000) was more precise and required a clear impairment in 
socialization as evidenced by impairments in verbal communication, nonverbal communication, 
or RRBIs.    
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 The subthreshold category of atypical autism arose following clinical accounts of 
individuals who were similar to those with autism, but did not exactly match Kanner’s (1943) 
definition of autism.  More specifically, these children had less severe language impairments and 
less impairing RRBIs (Despert & Sherwin, 1958).  Despite these diagnostic differences between 
children with PDD-NOS and autism, the inclusion of a “not otherwise specified” category 
received many criticisms.  Clinicians have argued that the diagnosis allowed for too much 
heterogeneity of symptom type and severity, and is unnecessary if autism is conceptualized as a 
spectrum of disorders.  The DSM-IV-TR was criticized for failing to clearly delineate the level of 
impairment that is needed for a child to meet criteria for ASD.  Towbin (2005) argued that the 
diagnostic criteria required clinicians to use categorical symptom descriptions to diagnose a 
dimensional variable.  In the end, clinicians were often left to use their own discretion to make 
final judgments.  Mahoney and colleagues (1998) found that clinicians could reliably distinguish 
between ASDs and non ASDs (κ = .67, 91% agreement); however, they were much less reliable 
in distinguishing between different categories of ASD (κ = .51, 73% agreement).  In particular, 
they found that clinicians were most likely to disagree about diagnoses involving PDD-NOS.   
 Mandy, Charman, Gilmour, and Skuse (2011) studied 66 individuals with PDD-NOS and 
found that, contrary to the popular belief that this group was completely heterogeneous, 97% of 
those with PDD-NOS fell within a single, distinct symptom presentation.  Those individuals all 
had impairments in social reciprocity and communication, without the presence of significant 
RRBIs.  Mandy and colleagues (2011) described the PDD-NOS group as a less severe 
presentation of autistic psychopathology.  They surmised that the DSM-5 criteria for Autism 
Spectrum Disorder would effectively exclude many of the individuals with PDD-NOS, because 
they would fail to meet the criteria for RRBIs.   
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In the past couple of years, a number of different research groups have specifically 
investigated changes to rates of ASD diagnosis by applying DSM-5 criteria in both retrospective 
and prospective manners.  McPartland and colleagues (2012) used a retrospective technique and 
found that only 28.3% of individuals diagnosed with PDD-NOS using DSM-IV-TR criteria would 
still cross the diagnostic threshold for Autism Spectrum Disorder using the DSM-5 criteria.  
Conversely, Huerta, Bishop, Duncan, Hus, and Lord (2012) argued that the DSM-5 criteria have 
improved specificity compared to the criteria for PDD-NOS in the DSM-IV-TR. 
1.3 Current Definitions of ASD 
 As of 2013, the two main diagnostic standards are the DSM-5 (APA, 2013) and the ICD-
10 (WHO, 1992).  The ICD-10 category for pervasive developmental disorders includes: 
Childhood Autism, Rett’s Syndrome, CDD, Asperger’s Syndrome, Atypical Autism, Other 
pervasive developmental disorder, Pervasive developmental disorder unspecified, and Overactive 
disorder associated with retardation and stereotyped movements.  Atypical autism in the ICD-10 
refers to individuals with late age of onset or subthreshold symptomatology.  PDD unspecified in 
the ICD-10 is used when an individual fits the general description for PDD, but the clinician 
either does not have the necessary information to diagnose a specific PDD or is presented with 
contradictory information.   
The fifth edition of the DSM was published in May 2013 and includes numerous changes 
to the diagnostic criteria for ASD (Mandy, Charman, & Skuse, 2012).  The first major change 
involves re-conceptualizing ASD as a dyad of impairments as opposed to the well-established 
triad that was developed by Wing and Gould (1979).  The two previously separate categories of 
socialization and communication were combined to form the new category ‘social 
communication.’  The second component of the dyad is RRBIs.  Another major change to the 
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diagnostic criteria involves eliminating the categories of ASD (e.g., Asperger’s Disorder and 
PDD-NOS) and subsuming all individuals under the heading ‘Autism Spectrum Disorder’ 
(Kaland, 2011).  This change is highly controversial, especially among individuals with 
Asperger’s Disorder who object to being group with individuals who have different symptom 
presentations (i.e., Autistic Disorder) and require different treatment modalities (Wing, Gould, & 
Gillberg, 2011).  The DSM-5 also introduced a new category called Social (Pragmatic) 
Communication Disorder, which consists of all the social and communication deficits seen in 
ASD without the presence of RRBIs (APA, 2013).  Researchers have hypothesized that some of 
the children who no longer meet criteria for ASD with the DSM-5 will meet criteria for this new 
diagnosis, which is grouped with the other communication disorders (Gibbs, Aldridge, Chandler, 
Witzlsperger, & Smith, 2012).   
The exact criteria for Autism Spectrum Disorder in DSM-5 requires that the individual 
present with persistent deficits in both social interaction and social communication in multiple 
contexts (APA, 2013).  Examples of symptoms include: deficits in social-emotional reciprocity 
(e.g., inability to maintain a conversation, lack of interest in initiating social contact); deficits in 
nonverbal communication that impairs social interaction (e.g., poor eye contact, lack of facial 
expressions, abnormal use of gestures); and deficits in developing age appropriate relationships 
(e.g., lack of pretend play, not interested in peers, difficulties making friends).  Secondly, the 
individual must exhibit two or more RRBIs out of four: 1) stereotypies (e.g., repetitive motor 
movements, abnormal use of objects, echolalia); 2) insistence on sameness (e.g., adherence to 
routines or rituals, difficulties with transitions, rigid thinking patterns); 3) restricted interests that 
are abnormal in focus or intensity; or 4) hyper- or hyposensitivity to visual, auditory, olfactory, 
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or tactile stimuli.  Additionally, the individual’s symptoms must be evident during the 
developmental period, effectively eliminating a rigid age-of-onset criterion.   
Finally, the diagnostic criteria require the clinician to specify the current severity level of 
the individual’s symptoms.  Level 1 would be ascribed to an individual “requiring support,” but 
whom is able to communicate to some degree and whose attempts to make friends are usually 
unsuccessful due to odd interaction style.  Level 2 would be ascribed to an individual “requiring 
substantial support” due to lack of social interaction and limited verbal and nonverbal 
communication skills.  Level 3 is the most severe and would be ascribed to an individual 
“requiring very substantial support” due to minimal or lack of speech, failure to initiate social 
interaction, and marked impairment from RRBIs.     
 Numerous studies have been published evaluating the validity of the DSM-5 criteria for 
ASD.  There are studies that support both sides of the argument.  For example, Mandy and 
colleagues (2012) evaluated 708 children with ASD and conducted a confirmatory factor 
analysis to determine if the DSM-5 model was superior to the triad approach of DSM-IV-TR.  
They reported that among individuals with autism who are higher functioning, ASD fits into a 
dyad model better than the previous triad of impairments.  Frazier and colleagues (2012), 
likewise, analyzed data from 14,744 siblings with and without ASD.  They applied the proposed 
DSM-5 algorithm and found that the DSM-5 had superior specificity (0.97 compared to 0.86); 
however, it had lower sensitivity (0.81 compared to 0.95).  The researchers then relaxed the 
DSM-5 criteria by requiring one less symptom criterion and this increased the sensitivity to 0.93, 
although the specificity was reduced to 0.95.  They concluded that the DSM-5 criteria had 
increased specificity and with slightly more relaxed criteria could allow for more accurate 
diagnoses. 
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 On the other side were the studies that raised concern about the DSM-5 criteria excluding 
a large portion of individuals who were previously diagnosed with ASD.  Mattila and colleagues 
(2011) applied the proposed criteria to a group of eight-year-old Finnish children and found that 
the DSM-5 was less sensitive, especially in regards to individuals previously diagnosed with 
Asperger’s Disorder and high-functioning individuals.  As stated previously in the section on 
Asperger’s Disorder, McPartland and colleagues (2012), likewise, found that when the DSM-5 
criteria was applied to individuals from the DSM-IV field trial, only 60.6% of the individuals 
who were previously diagnosed with ASD still received the diagnosis.  Worley and Matson 
(2012) assessed 281 children utilizing both the DSM-IV-TR and DSM-5 criteria for purposes of 
comparison.  They found that the children who no longer met criteria for ASD using the DSM-5 
criteria had similar symptom severity to those children who still met criteria.  Further, the 
children no longer meeting criteria differed significantly from typically developing children.  
Thus, the new diagnostic criteria appears to have decreased sensitivity and the broader 
classification used by the DSM-IV-TR appears to be superior for identifying all children with 
significant impairments in these core areas.   
In another study, researchers evaluated the rates of diagnosis using the new and old 
criteria and they found that 36.53% of adults who met criteria for ASD according to the DSM-IV-
TR no longer met criteria according to the DSM-5 (Matson, Belva, Horovitz, Kozlowski, & 
Bamburg, 2012).  Likewise, Taheri and Perry (2012), found that 37% of previously diagnosed 
individuals no longer met criteria using the DSM-5.  More specifically, only 17% of individuals 
previously diagnosed with PDD-NOS met criteria for ASD.  To account for these discrepancies, 
the DSM-5 includes the caveat that individuals who were previously diagnosed with ASD with 
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the DSM-IV-TR should be given a DSM-5 diagnosis of ASD regardless of whether they meet the 
new criteria. 
1.4 Prevalence of ASD 
ASD was once considered to be relatively rare, but is now described by some as epidemic 
in the United States.  In the last decade alone, there has been a 78% increase in the prevalence 
rate (Baio, 2012).  There are numerous hypotheses for the increased rate of diagnosis, with many 
researchers arguing that the numbers do not denote an actual increase in incidence.  Wing and 
Potter (2002) proposed some specific explanations for the changing rates including: 1) frequently 
updated diagnostic criteria; 2) differences in methods used for diagnosis between prevalence 
studies; 3) research to support that ASD can co-occur with intellectual disability, physical 
disability, or psychological disorder; 4) increased availability of public and private services for 
individuals with ASD; and 5) increased awareness about the disorder among physicians and 
caregivers.  They also provided the caveat that the increasing numbers could represent a true 
increase in the prevalence of the disorder.  
 As per the first two proposed explanations, there have been numerous revisions to the 
DSM and ICD criteria for ASD since the disorder was initially introduced by Kanner in 1943.  
For instance, the disorder was not officially recognized in the DSM until the publication of the 
DSM-III in the 1980s.  Additionally, early definitions of ASD did not allow for a diagnosis if the 
individual had subthreshold symptomatology in any of the three core deficits.  To account for 
heterogeneity and the conceptualization of autism as a “spectrum disorder,” each revision to the 
DSM has included different subgroups under the PDD heading.  This constant shifting in 
diagnostic categories led to variability in which diagnostic criteria were used for any given 
prevalence study.  Additionally, different researchers utilized different participants (i.e., age, 
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gender, socioeconomic status [SES]).  Fombonne (2003) indicated that studies conducted with a 
smaller number of participants resulted in higher rates of ASD prevalence.  Higher rates were 
also found in studies with a higher percentage of immigrants (Wing & Potter, 2002)   
 As per the third point presented by Wing and Potter (2002), ASD was initially described 
by Kanner (1943) as occurring solely in children of average intelligence.  Researchers now 
consider ASD to occur at fairly high rates in individuals with ID.  Baird and colleagues (2006) 
found that 50% to 70% of individuals with ASD also had ID.   Further, diagnostic criteria now 
allows for a diagnosis of ASD in children with above average intelligence.  These children are 
most often diagnosed with Asperger’s Disorder, which was not introduced to the DSM until 
1994.  Moreover, researchers have only recently begun to focus on comorbidity with other 
psychiatric disorders (Clark, Feehan, Tinline, Vostanis, 1999; De Bruin, Ferdinand, Meester, de 
Nijs, & Verheij, 2007; Ghaziuddin, Ghaziuddin, & Greden, 2002; Ghaziuddin, Tsai, & 
Ghaziuddin, 1992; Ghaziuddin, Weidmer-Mikhai, & Ghaziuddin, 1998; Leyfer et al., 2006; 
Matson & Nebel-Schwalm, 2007b; Smith & Matson, 2010).  Specific studies of comorbidity will 
be discussed in more detail in subsequent sections.       
With increases in prevalence have come increased demand for specialized services in the 
schools and larger community that address the needs of children with ASD.  Unfortunately, some 
children are more likely than others to gain access to such services, and this may partly explain 
discrepancies between demographic groups in rates of diagnosis.  Thomas, Ellis, McLaurin, 
Daniels, and Morrissey (2007) found that access to care was more limited for families from 
racial and ethnic minority groups.  Likewise, Liptak and colleagues (2008) found that ASD was 
likely being underdiagnosed in children from racial minorities, especially those from families of 
low SES who are traditionally underserved in the health care system.  Despite these disparities, 
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there has been a marked improvement in the availability of services since the Individuals with 
Disabilities Education Act (IDEA) officially recognized ASD in 1991.  In the 10 years following 
the introduction of this legislation, the rates of ASD went from 3 per 10,000 to 52 per 10,000 
(Gurney, Fritz, Ness, Sievers, Newschaffer, & Shapiro, 2003).  In order to best serve the child, 
both parents and professionals are more likely to consider a diagnosis of ASD when there are 
services available to improve that child’s prognostic outcome (Wing & Potter, 2002).   
Moreover, increased public awareness of ASD has led to the formation of parent support 
groups and advocacy groups that aid parents in identifying qualified professionals to evaluate 
and treat their children.  These groups have pushed for research on the etiology and treatment of 
these disorders leading to increased public and private funding for empirical studies (Singh, Illes, 
Lazerroni, & Hallmayer, 2009).  As of yet, there is no research that draws any causal 
relationships between these factors and the increased prevalence of ASD.  Wing and Potter 
(2002) suggest that future research is needed to more fully address these proposed explanations.   
The most recent estimates from the Center for Disease Control place the rate of ASD as 1 
in 88 children (Baio, 2012).  The Autism and Developmental Disabilities Monitoring Network 
collected data on children aged 8 years from 14 different sites across the United States.  In total, 
337,093 children were reviewed and 3,820 met criteria for an ASD.  The rates ranged between 
sites from 4.8 per 1,000 in Alabama to 21.2 in 1,000 in Utah.  Prevalence rates significantly 
differed according to gender, with ASD occurring in one in 54 males as opposed to one in 252 
females.  Additionally, the sites identified significantly more non-Hispanic white children with 
ASD than non-Hispanic black children and Hispanic children.  In comparison to the 2006 
surveillance year, ASD prevalence increased 23%.         
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Kim and colleagues (2011) evaluated the prevalence of ASD in South Korea among 7 to 
12 year-old children.  The researchers screened 36,886 children attending elementary schools in 
the Islan district of Goyang City, South Korea.  The study consisted of a 2 step diagnostic 
process.  All children were screened for possible ASD, and then those who screened-positive 
(1,214 children) received further evaluation.  The crude prevalence of all ASDs was found to be 
0.36%, however, following statistical adjustment for nonparticipants (37%) the overall ASD 
prevalence was estimated to be 2.64% with 1.89% in the general sample and 0.75% in the high-
probability group.  The researchers acknowledge that this may be a slight overestimate 
considering previous estimates ranged from 0.6% to 1.8% prevalence (Fombonne, 2009).  
However, an estimated two-thirds of the children meeting criteria for ASD were previously 
undiagnosed and untreated, bringing into question the comprehensiveness of the established 
detection methods.  
1.5 Etiology of ASD 
 Increased public interest in the disorder has led to increased empirical research on the 
etiology of ASD.  Prior to the last few decades, explanations of etiology were largely theoretical 
as opposed to evidence-based.  Kanner (1943) initially theorized that autism had a biological 
origin, but could not identify a clear precipitant.  He included a more thorough description of 
some of the interpersonal difficulties he observed between the children with autism and their 
parents.  These interpersonal factors mapped easily into the psychodynamic theories of the era 
and became the main focus of early descriptions of etiology.  Eveloff (1960), for example, 
crafted his case studies with a direct focus on parent-child relational problems.  He described the 
mothers as cold, impersonal, and rigid, while the fathers were perfectionistic and detached from 
their children.  These parental characteristics were thought to both contribute to and maintain the 
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child’s symptoms.  This theory was expanded upon by Bettelheim (1967), who coined the term 
“refrigerator mothers” to describe this pattern of maternal relational characteristics and rearing 
style that supposedly led to autistic behavior in children.  Empirical studies proved time and 
again that these theories were unfounded, and that there was no link between child-rearing 
practices and the development of autism (Pitfield & Oppenheim, 1964).  Despite these findings, 
parents and especially mothers of children with autism still often blame themselves for their 
child’s difficulties (Matson & Minshawi, 2006).  
1.5.1 Learning Theories 
 Behavioral theories gained popularity in the first part of the 20
th
 century, but were not 
immediately applied to research on ASD.  Philips (1957) summarized the literature to date 
linking ASD with learning theory formulations and found there to be a dearth of research in the 
area.  Ferster (1961), who worked with Skinner on the operant conditioning model of learning 
(Ferster & Skinner, 1957), acknowledged this insufficiency and made the first true attempts to 
explain the etiology of ASD using learning principles.  He proposed that ASD symptomology 
resulted from the persistent failure to provide social praise or parental attention in response to 
desired behaviors.  Therefore, the child never learned to associate these social responses with 
positive reinforcement.  However, Ferster noted that children with ASD could learn new 
behaviors, as evidenced by the effectiveness of primary reinforcers (i.e., food) to foster learning 
in an operant conditioning procedure (Ferster & DeMeyer, 1961).  Again, the idea that parental 
reactions to behavior caused ASD has been refuted by empirical research, but these behavioral 
principles became key components of treatments for children with ASD. 
 This early work was the basis for Lovaas and Smith’s (1989) behavioral theory of ASD, 
which is broken down into four basic principles.  First, they offered that learning theory accounts 
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for the patterns of behaviors characteristic of children with ASD and the basic laws of learning 
can be adapted into interventions tailored to these behaviors.  Second, the researchers 
acknowledged that the behaviors are not all learned and that some are due to developmental 
delays, which might never by remediated even with intensive treatment.  Third, they proposed 
that children with ASD can learn skills when they are taught in a controlled environment 
adhering to specific reinforcement schedules.  Finally, the researchers stated that a child with 
ASD is capable of mastering new learning when environmental variables are highly controlled 
and tailored to the individual child.  Using these tenets for guidance, the researchers developed a 
behavior therapy that focuses on specific behaviors and how they can be changed in the present 
as opposed to where they originated from in the past.  Thus, behavioral views of ASD are fairly 
unique among other etiological theories in that they are present focused.  
1.5.2 Genetics 
The new information garnered from behavioral theories led to a shift in the other types of 
research being conducted on ASD.  In the first part of the 20
th
 century, little attention was paid to 
possible genetic explanations for ASD, because qualitative research indicated that children with 
ASD were not typically born from parents with ASD and there was not a clear chromosomal 
anomaly that could account for the disorder (Rutter, 1968).  Further, early studies did not find 
high rates of concordance among siblings.  However, more recent studies have focused on twins 
and found relatively high rates of concordance indicative of genetic factors being involved in the 
etiology of the disorder.  For example, Folstein and Rutter (1977) examined 11 pairs of 
monozygotic and 10 pairs of dizygotic twins.  They found a 36% pair-wise concordance rate for 
ASD in monozygotic twins as compared to no concordance in dizygotic twins.  This finding is 
thought to be a low estimate based on the stricter diagnostic criteria of the time period (Folstein 
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& Rutter, 1988).  A later study using a larger sample by Ritvo, Freeman, Mason-Brothers, Mo, 
and Ritvo (1985), reported a much higher concordance rate of 95.7% among monozygotic twins 
and 23.5% concordance among dizygotic twins.  There were admittedly some methodological 
concerns with these early studies (e.g., no random sampling and use of parental report to 
determine zygosity), but the findings provided early evidence that ASD occurred in both types of 
twins at a higher rate than would predicted by chance.  A more recent study found similarly high 
rates of genetic heritability for autistic traits.  Ronald and colleagues (2006) screened 3,419 
eight-year old twin pairs in the United Kingdom.  In 75% of the cases, zygosity was determined 
using DNA samples.  They found overall concordance rates of 80.0% for monozygotic twins and 
21.5% for dizygotic twins.  Further, genetic modeling allowed them to investigate correlations 
between the three main components of ASD.  The researchers found that distinct genetic 
influences were responsible for each of the components lending support to the theory that the 
genetic factors involved in ASD are highly heterogeneous.     
An alternative method for studying genetic factors is to study the non-twin siblings of 
individuals with ASD.  Early studies reported rates that ranged between 3% and 10% for 
recurrence in the sibling of a child with ASD (August, Stewart, & Tsai, 1981; Bolton et al., 1994; 
Chakrabarti & Fombonne, 2001; Lauritsen, Pedersen, & Mortensen, 2005).  More recently, 
Constantino, Zhang, Frazier, Abbacchi, and Law (2010) found a recurrence rate of 10.9%.  They 
also reported that an additional 20% of the non-ASD siblings had a history of speech delay.  
Ozonoff and colleagues (2011) conducted a prospective longitudinal study of 664 infants at risk 
for ASD whom had an older sibling with ASD.  They found that 18.7% of these at risk infants 
developed ASD by 36 months of age.  Some possible explanations for these discrepancies in 
recurrence rates are that early studies were limited by small sample sizes and biases in reporting.   
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The association between ASD and specific genetic disorders is a third piece of evidence 
in support of a genetic etiology of ASD (Klauck, 2006).  The relationship between Fragile X 
Syndrome, an X-linked recessive disorder, and ASD is well established.  Fragile X has been 
identified as the second most common known genetic cause of intellectual disability after Down 
syndrome (Brown et al., 1982).  Brown and colleagues (1986) compiled the results from 12 
studies, including their own, where a total of 614 males with ASD were screened for Fragile X.  
They reported that 47 of the males were positive for the syndrome, which equates to a 7.7% 
frequency of Fragile X among males with ASD.  Further, an estimated 12.3% of males with 
Fragile X met criteria for ASD.  The researchers suggest genetic testing for all individuals with 
ASD with specific emphasis on screening for the Fragile X marker.   
A recent literature review identified 44 genetic disorders and 103 disease genes that are 
found in individuals with ASD or associated with autistic symptoms (Betancur, 2011).  Each of 
these account for only a small number of ASD cases and suggest a highly heterogeneous genetic 
etiology.  Some of the disorders identified as being highly comorbid with ASD include 22q13 
deletion syndrome, tuberous sclerosis, and adenylosuccinate lyase deficiency.  Despite increased 
research into genetic factors, many causes of ASD have yet to be identified and researchers 
caution against placing too much emphasis on genetic testing (Herman, Henninger, Ratliff-
Schaub, Pastore, Fitzgerald, & McBride, 2007).   
1.5.3 Neurobiology 
With increased knowledge about the structure and function of areas in the brain, 
researchers have suggested that neurobiological factors play an important role in explaining the 
etiology of ASD.  The high rate of comorbid ID in individuals with ASD lends further support to 
the notion that abnormalities in neurobiology are probable causal mechanisms in ASD (Matson 
 32 
 
& Minshawi, 2006).  Specific neurobiological deficits in ASD include gait disturbances, 
clumsiness, sensitivity to sensory stimuli, and epilepsy (Ben-Sasson, Hen, Fluss, Cermak, Engel-
Yeger, & Gal, 2009; Fournier, Hass, Naik, Lodha, & Cauraugh, 2010; Levisohn, 2007; Vilensky, 
Damasio, & Maurer, 1981).  The connection between epilepsy and ASD has been a focus of 
neurological research in recent years.  The disorder is estimated to effect 5% to 38% of 
individuals with ASD (Danielsson, Gillberg, Billstedt, Gillberg, & Olsson, 2005; Tuchman & 
Rapin, 2002).  Moreover, the risk of epilepsy is higher in those with comorbid ID or cerebral 
palsy (Tuchman & Rapin, 2002).   
At present, multiple areas of the brain have been suggested as the center of dysfunction in 
ASD including the amygdala, basal ganglia, cerebellum, and thalamus (Vargas, Nascimbene, 
Krishnan, Zimmerman, & Pardo, 2005).  Schumann, Barnes, Lord, and Courchesne (2009) 
investigated the developmental trajectory of the amygdala in children with ASD and found that 
the amygdala was enlarged in comparison to typically developing toddlers.  Further, they found 
that in male toddlers who developed ASD, the degree of enlargement was correlated with the 
severity of their socialization and communication impairments.  The amygdala is involved in the 
production and recognition of emotions as well as modulating social behavior (Adolphs, 2008).  
Thus, the pattern of impairments in ASD may be attributable to amygdala dysfunction.  As for 
the basal ganglia, researchers have found that abnormalities in the structure are associated with 
motor, communication, and social deficits in male children with ASD (Qui, Adler, Crocetti, 
Miller, & Mostofsky, 2010).  The basal ganglia has also been implicated in postural 
abnormalities of the trunk and head that are common in individuals with ASD (Rinehart et al., 
2006).  The cerebellum has also been linked to some of the characteristic motor impairments in 
children with ASD, especially abnormalities in gait function (Rinehart et al., 2006).  Cerebellar 
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dysfunction in children with ASD is thought to be due to decreased vermis volume; however, the 
data is inclusive at present (Scott, Schumann, Goodlin-Jones, & Amaral, 2009).  Finally, the 
thalamus has been identified as playing a possible role in the pathophysiology of ASD, and more 
specifically the development of abnormal sensory responses (Harden et al., 2008).   
Aside from structural abnormalities, researchers have also investigated the role of 
neurotransmitters in ASD.  The most commonly researched neurochemical in individuals with 
ASD is serotonin (Matson & Minshawi, 2006), which is likely due to its role in psychotropic 
medications (i.e., selective serotonin reuptake inhibitors [SSRIs]) that are commonly prescribed 
to individuals with ASD.  Abnormalities in serotonin levels in the bloodstream were first linked 
to ASD by Schain and Freedman (1961), who reported elevated levels of 5-hydroxyindole in 
children with ASD.  This finding is critical, because serotonin plays a major role in cortical 
development and specifically areas of the brain that are impaired in children with ASD (Chugani, 
2004).  The abnormal serotonin levels in individuals with ASD have been linked to a variety of 
behavioral symptoms.  Kolevzon and colleagues (2010), for example, reported that serotonin 
level was inversely related to presence of self-injurious behavior (SIB) in individuals with ASD.  
However, the studies on serotonin and behavioral symptoms of ASD have been inconsistent 
overall and controversy remains over the use of SSRIs with this population (Hranilovic, Bujas-
Petkovic, Vragovic, Vuk, Hock, & Jernej, 2007). 
Another neurotransmitter that has been linked to ASD is gamma-aminobutyric acid 
(GABA), which is the main inhibitory chemical in the brain (Collins et al., 2006).  The high rates 
of epilepsy in individuals with ASD may be related to a reduced number of GABA receptors 
(Fatemi, Folsom, Reutiman, & Thuras, 2009).  Researchers have proposed that the brain of 
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individuals with ASD is overstimulated and unable to filter out unnecessary external stimuli due 
to a lack of GABA (Hussman, 2001). 
A third group of neurotransmitter that has been linked to ASD are endogenous opioids, 
which have been specifically associated with SIB in individuals with ASD (Gillberg, 1995).  One 
theory for this link is related to the finding that high levels of endorphins in children with ASD is 
associated with reduced pain reactivity (Tordjman et al., 2009).  Additionally, Tordjman and 
colleagues (2009) found that the level of endorphins in blood plasma was positively correlated 
with severity of ASD symptoms.  Endogenous opioids have also been linked to prosocial 
behaviors including social bonding, with these social interactions resulting in an endorphin 
release (ElChaar, Maisch, Augusto, & Wehring, 2006; Wink, Plawecki, Erikson, Stigler, & 
McDougle, 2010).  Thus, the socialization impairments that are characteristic of children with 
ASD may be due to high levels of endogenous opioids that negate the opioid reward that comes 
from social interaction (Machin & Dunbar, 2011).  Further research is needed to elucidate the 
exact roles of neurotransmitters in the etiology of ASD.  
1.5.4 MMR Vaccine 
 In 1998, Wakefield and colleagues published their theory that autism was caused by the 
measles, mumps, and rubella (MMR) immunizations.  The initial purpose of their study was to 
investigate the relationship between gastrointestinal conditions (i.e., chronic enterocolitis) and 
regressive ASD in 12 children aged 3 to 10 years.  Wakefield and colleagues (1998) reported that 
in 8 of the 12 children, administration of the MMR vaccine was followed by loss of acquired 
skills (i.e., language abilities) and development of gastrointestinal symptoms (i.e., diarrhea, food 
intolerance, and abdominal pain).  Parents reported that the first behavioral symptoms occurred 
an average of 6.3 days after the immunization.  The researchers hypothesized that some 
 35 
 
component of the vaccine caused increased permeability of the intestines leading to excessive 
absorption of gut-derived peptides.  They proclaimed this phenomenon to be the basis of a new 
syndrome, which they termed ‘autistic enterocolitis,’ because the absorption of peptides led to 
the development of autistic behaviors in these children.  Wakefield and colleagues (1998) were 
careful not to suggest a causal link between the MMR vaccine and autism; however, they 
advocated that parents stop allowing their children to receive the vaccination.  The publication 
caused immediate controversy and led to an increase in the number of parents refusing the 
vaccine despite subsequent evidence against Wakefield’s findings (Brown et al., 2012).   
In the years following the article’s publication, numerous studies were published that 
found no evidence to support a link between ASD and the MMR vaccine (Honda, Shimizu, & 
Rutter, 2005; Madsen et al., 2002; Taylor, Miller, Lingam, Andrews, Simmons, & Stowe, 2002).  
Furthermore, numerous concerns were brought against Wakefield regarding the methodology of 
the study.  First, no control group was utilized in the study, so all the findings could be merely 
coincidental.  Second, only one child included in the study was later found to meet the criteria 
for ‘regressive autism,’ and three of the children did not even have ASD (Deer, 2011).  Further, 
more evidence surfaced that some of the children had gastrointestinal problems prior to the 
MMR vaccine.  Finally, the only children included in the study were those who had 
developmental delays and gastrointestinal concerns, as Wakefield did not use random sampling 
to recruit participants.  Following a thorough investigation by Deer (2011), Wakefield and 
colleagues’ (1998) article was retracted from the Lancet in 2010.  Additionally, Wakefield was 
found guilty of subjecting the children in his study to intrusive procedures that disregarded 
ethical standards and stripped of his medical license by the United Kingdom General Medical 
Council (Dyer, 2010).   
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The past two decades have resulted in a great influx of research on the etiology of ASD.  
There is evidence to support multiple causalities of this highly heterogeneous disorder.  Thus, it 
appears to be most likely the case that ASD is the result of multiple etiological factors and these 
may differ between individuals.   
1.6 Comorbid Disorders 
Comorbidity is the term used when an individual presents with two or more disorders.  In 
the context of the current research, comorbidity refers to an individual who is diagnosed with 
ASD and another disorder.  In these instances, ASD is typically considered the primary disorder 
and the comorbid disorders are considered secondary (Matson & Nebel-Schwalm, 2007b).  ASD 
is primary because it tends to be the most interfering on functional domains.  Simonoff, Pickles, 
Charman, Chandler, Loucas, and Baird (2008) assessed 112 children with ASD and reported that 
70% had at least one comorbid disorder and 41% met criteria for two or more disorders.  In some 
instances, researchers and clinicians have debated whether these disorders should even be 
diagnosed in individuals with ASD or instead considered associated symptoms.               
1.6.1 Attention-Deficit/Hyperactivity Disorder (ADHD) 
The most commonly studied comorbid disorder in individuals with ASD is attention-
deficit/hyperactivity disorder (ADHD) as the behavioral symptoms of the two disorders often 
overlap leading to difficulties with differential diagnosis (Lovell, Moss, & Wetherell, 2012; 
Matson & Nebel-Schwalm, 2007b).  ADHD is a neurobehavioral disorder that is estimated to 
occur in 2% to 17% of the total population (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003; 
Froehlich, Lanphear, Epstein, Barbaresi, Katusic, & Kahn, 2007).  The disorder is characterized 
by hyperactivity, inattention, and impulsivity (Barkley, 1981; Barkley, 1997; Burns, Boe, Walsh, 
Sommers-Flannagan, & Teegarden, 2001).  These symptoms are only considered clinically 
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significant when they occur at a frequency or intensity that is greater than would be expected for 
an individual at that developmental level (Luk, 1985).  Children with ADHD are at increased risk 
for functional impairments including poor coordination (Fliers et al., 2008; Kadesjo & Gillberg, 
1998; Wilson, 2005), social skill deficits (Booster, DuPaul, Eiraldi, & Power, 2012; de Boo & 
Prins, 2007; DuPaul, McGoey, Eckert, & VanBrakle, 2001), and learning difficulties (Hinshaw, 
1992; Rapport, Scanlan, & Denney, 1999).  These difficulties begin in early childhood and can 
persist into adulthood (Gadow, Sprafkin, & Nolan, 2001; Hechtman, 2000; Wilens, Biederman, 
& Spencer, 2002). 
Prevalence estimates have found ADHD to be one of the most commonly comorbid 
disorders in individuals with ASD.  Simonoff and colleagues (2008) reported a rate of 28.2% of 
children with ASD who had comorbid ADHD.  Likewise, Leyfer and colleagues (2006) reported 
a rate of 30.6% among children with ASD.  Other researchers report even higher rates of 
comorbid ADHD ranging from 59% to 78% (Goldstein & Schwebach, 2004; Holtmann, Bolte, & 
Poustka, 2007; Lee & Ousley, 2006).  The two disorders have some shared symptoms, but they 
also have numerous disorder-specific symptoms, supporting the argument that they are distinct 
and separable diagnoses (Chnstakou et al., 2013; Di Martino et al., 2013; van der Meer et al., 
2012).  Identifying comorbid ADHD symptoms in children with ASD is critical, because they 
compound the impairments leading to poorer prognosis (Frazier et al., 2001).  Sinzig, Walter, 
and Doepfner (2009) investigated ADHD symptoms in 83 children with ASD.  They found that 
symptoms of hyperactivity were significantly correlated with severity of communication deficits 
and symptoms of inattention were significantly correlated with stereotyped behaviors.  
Additionally, children with ASD and ADHD exhibit significantly more externalizing symptoms 
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(Tureck, Matson, May, & Turygin, 2013) and functional impairments (Yerys, Wallace, Sokoloff, 
Shook, James, & Kenworthy, 2009) than children with only one of the disorders. 
1.6.2 Anxiety Disorders 
 Anxiety and phobic disorders are the most commonly comorbid disorders in individuals 
with ASD (Leyfer et al., 2006; Simonoff et al., 2008).  However, some researchers have argued 
that anxiety is not always a true comorbid disorder, but rather a manifestation of ASD 
symptomatology (Kerns & Kendall, 2013).  In particular, social avoidance, as well as ritualistic 
and compulsive behavior are central to ASD and some anxiety disorders (Wood & Gadow, 
2010).  Leyfer and colleagues (2006) proposed that social avoidance in ASD and social anxiety 
are separable, because children with ASD avoid social situations due to non-social factors (e.g., 
loud noises) as opposed to intentionally avoiding social interactions.  Further, generalized 
anxiety disorder (GAD) was found to be different from the anxiety inherent to ASD 
symptomatology, because GAD involves anxiety about multiple things as opposed to anxiety 
about transitions or insistence on sameness.  Diagnosing anxiety disorders in children with ASD 
is further confounded by communication deficits, which prohibit many children with ASD from 
expressing internalizing symptoms (Davis et al., 2011).      
 The prevalence of anxiety disorders in children with ASD is estimated to be between 
11% and 84% (White, Oswald, Ollendick, & Scahill, 2009).  The rates are highly variable due 
the unfortunate tendency for clinicians not to diagnose anxiety disorders (especially social 
phobia and obsessive compulsive disorder) in children with ASD (White et al., 2009).  However, 
they are still consistently higher than in typically developing children, where the prevalence is 
estimated to be between 2.2% and 27% (Costello, Egger, & Angold, 2005).  Leyfer and 
colleagues (2006) reported that specific phobias were the most common comorbid disorder with 
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ASD occurring at a rate of 44.3%.  Obsessive compulsive disorder (OCD) was the second most 
common, occurring at a rate of 37.2%.  Simonoff and colleagues (2008) conversely found that 
social phobia was the most commonly comorbid disorder, occurring in 29.2% of children with 
ASD.  Despite these diagnostic discrepancies, researchers are in agreement that anxiety disorders 
occur at a high rate in children with ASD and cause additional behavioral difficulties (Kim, 
Szatmari, Bryson, Steiner, & Wilson, 2000). 
1.6.3 Mood Disorders 
 In an early study on comorbidity in individuals with Asperger’s Disorder, Wing (1981) 
reported that depression was the most common comorbid psychiatric condition.  Depression is 
more common in adolescents and adults with ASD than children (Ghaziuddin et al., 1998).  One 
explanation for this discrepancy might be related to how symptoms present at different ages.  For 
example, Leyfer and colleagues (2006) reported that only 10% of children with ASD met criteria 
for Major Depressive Disorder (MDD); however, this rate increased to 24% for ‘subsyndromal’ 
(i.e., falls just short of the diagnostic criteria, but is significantly impairing) major depression.  
These subsyndromal cases are important to consider, because some diagnostic criteria may not 
be applicable to children with ASD due to cognitive, developmental, or language limitations 
(Kendler & Gardner, 1998).  This discrepancy was confirmed by Simonoff and colleagues 
(2008), who reported that only around 1% of children with ASD met criteria for MDD; however, 
an additional 10.9% had experienced a significant period of subsyndromal depression or 
irritability. 
 Diagnosing depression in individuals with ASD can pose a challenge to clinicians as the 
child will rarely report depressed mood, so the clinicians must rely on parent report of increased 
irritability, loss of interest, and other features of the disorder (Stewart, Barnard, Pearson, Hasan, 
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& O’Brien, 2006).  Another concern is that symptoms of ASD may mask some of the symptoms 
of depression (Magnuson & Constantino, 2011).  For example, children with ASD who develop 
depression exhibit increases in ritualistic behavior, obsessions, and hyperactivity (Ghaziuddin et 
al., 2002).  Thus, caregivers must be observant of increasing ASD symptom severity, because 
few children with ASD are able to effectively communicate feelings of depressed mood or loss 
of interest.  Researchers have also noted that depression in children with ASD often leads to an 
increase or onset of challenging behavior (e.g., SIB, aggression) highlighting the need for 
effective diagnostic measures tailored to this population (Clarke, Baxter, Perry, & Prasher, 1999; 
Long, Wood, & Holmes, 2000).  One theory is that the increase in SIB is related to the child’s 
increasingly negative self-view (Skinner, Ng, McDonald, & Walters, 2005; Stewart et al., 2006). 
 Bipolar disorder in children with ASD has just recently begun to receive attention from 
researchers.  Frazier, Doyle, Chiu, and Coyle (2005) presented the case of a 13-year-old boy with 
Asperger’s Disorder who was exhibiting extreme violence and aggression.  Upon evaluation, the 
clinicians reported sleep disturbances, irritability, obsessions, pressured speech, and racing 
thoughts.  Most concerning, he had recently presented with symptoms of depression and 
expressed suicidal ideation.  The patient was diagnosed with Bipolar Disorder, Mixed, with 
Psychotic Features.  Upon the introduction of Lithium treatment, the patient began exhibiting 
more regulated mood symptoms and fewer aggressive behaviors.  Frazier and colleagues 
provided this case presentation to encourage researchers and clinicians to consider diagnosing 
comorbid bipolar disorder in adolescents with ASD as opposed to attributing the symptoms to 
the ASD diagnosis.     
 Overall rates of hypomanic/manic disorders (i.e., bipolar disorder, hypomanic episodes, 
manic episodes, and mixed episodes) are relatively low in children with ASD with less than 1% 
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meeting diagnostic criteria (Leyfer et al., 2006).  The prevalence is considerably higher in 
adolescents with high-functioning ASD.  Munesue, Ono, Mutoh, Shimoda, Nakatani, and 
Kikuchi (2008) assessed 44 adolescents with ASD and an IQ greater than 70 and reported that 
27% met criteria for bipolar disorder.  This is in line with other researchers who reported that 
rates of mood disorders significantly increased in adolescence as compared to early childhood 
(Ming, Briacombe, Chaaban, Zimmerman-Bier, & Wagner, 2008).   
1.6.4 Motor Disorders and Tourette Syndrome 
 The rates of motor disorders are higher in children with ASD than among typically 
developing children.  At present, these associated features are not diagnostic, but can cause 
impairments in activities of daily living.  Researchers have long reported that children with ASD 
experience clumsiness, postural abnormalities, and fine or gross motor deficits at higher rates 
than typically developing children (Bauman, 1992; Fournier et al., 2010; Rapin, 1997).  These 
deficits are noticeable prior to 2 years of age and often persist across the lifespan (Teitelbaum, 
Benton, Shah, Prince, Kelly, & Teitelbaum, 2004).  Green and colleagues (2009) evaluated 
movement skills in 101 children with ASD and found that 79% exhibited significant impairments 
and an additional 10% exhibited borderline impairments.     
 Tourette syndrome (TS) is a specific type of motor disorder that is characterized by 
chronic motor and vocal tics that occur at random times.  Researchers estimate that the current 
rate of TS is between 0.3 and 1% of the population (Robertson, Eapen, & Cavanna, 2009; Scharf, 
Miller, Matthews, & Ben-Shlomo, 2012).  In the past few decades, researchers have focused on 
the relationship between TS and ASD working under the assumption that the two disorders likely 
have some common etiological factors (Canitano & Vivanti, 2007).  Some of the behavioral 
symptoms of the two disorders directly overlap, including echolalia, palilalia (i.e., involuntary 
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repetition of syllables, words, or phrases using contextually correct speech), and 
obsessions/compulsions (Stern & Robertson, 1997).  Moreover, individuals with both disorders 
exhibit repetitive motor movements, although these are typically spontaneous in those with TS 
and more stereotyped in those with ASD (Rapin, 2001).  Canitano and Vivanti (2007) evaluated 
the prevalence of tic disorders and TS in 105 children with ASD.  Overall, 22% of the children 
presented with tic disorders, which was broken down to 11% with TS and 11% with chronic 
motor tics.  Simonoff and colleagues (2008) reported a much lower rate of 4.8% of children with 
ASD meeting criteria for TS.  Again, an additional 9% of children with ASD exhibited chronic 
tic disorder.  Considering this high degree of comorbidity, more research is needed to delineate 
the association between these two disorders.   
1.6.5 Disruptive Behavior Disorders 
 Oppositional defiant disorder (ODD) is a disruptive behavior disorder characterized by a 
pattern of disobedient, hostile, and purposefully defiant behavior toward adults (APA, 2013).  
Children with ODD often exhibit temper tantrums, deliberately annoy others, blame others for 
own mistakes, and are irritable (Hamilton & Armando, 2008).  Leyfer and colleagues (2006) 
reported that ODD has a prevalence of 7% in children with ASD, which is similar to the 
prevalence in the overall population of 8.5% (Kessler, Beglund, Demler, Jin, Merikangas, & 
Walters, 2005).  However, other researchers have estimated the prevalence of ODD in ASD to be 
much higher at around 28% (Gadow, DeVincent, Pomeroy, & Azizian, 2004; Simonoff et al., 
2008).  Gadow, DeVincent, and Drabick (2008) investigated whether ODD was separable from 
other symptoms of ASD and found that ODD is a distinguishable behavioral syndrome resulting 
in more severe challenges than in children with ASD who do not have ODD.  Conduct disorder 
is a more severe form of disruptive behavior where the child engages in a pattern of behavior that 
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violates the basic rights of others and other societal norms.  Simonoff and colleagues (2008) 
estimated the rate of conduct disorder to be 3.2% of children with ASD. 
1.7 Co-Occurring Challenging Behavior 
 Children with ASD often exhibit one or more challenging behaviors requiring 
intervention (Matson & Minshawi, 2007).  Challenging behavior is defined as “culturally 
abnormal behavior(s) of such intensity, frequency or duration that the physical safety of the 
person or others is likely to be placed in serious jeopardy, or behavior which is likely to seriously 
limit use of, or result in the person being denied access to, ordinary community facilities” 
(Emerson, 2001, p. 3).  Specific examples of challenging behavior are physical aggression, pica 
(i.e., eating inedible objects), SIB, tantrum behavior, and stereotypies.  These behaviors are 
considered to co-occur with ASD, because they are central to conceptualizations of the disorder 
but are not core diagnostic features (Matson & Nebel-Schwalm, 2007a).  An estimated 82% of 
children with ASD display challenging behavior and 96% of these exhibit more than one form 
(Murphy, Healy, & Leader, 2009).  Furthermore, severity of ASD symptoms is significantly and 
positively correlated with the number and intensity of challenging behavior, such that those with 
more severe ASD exhibit more challenging behavior (Matson, Wilkins, & Macken, 2008). 
 Researchers have investigated specific risk factors for the development of challenging 
behavior in individuals with ASD.  One factor appears to be the age of the individual, with 
challenging behavior reaching a peak in adolescence and early adulthood (Holden & Gitlesen, 
2006).  However, this finding does not appear to be universally true, as SIB actually tends to 
decrease with age (Baghdadli, Pascal, Grisi, & Aussilloux, 2003).  One theory for this decrease is 
that children with ASD develop better adaptive skills that result in a decrease in SIB.  Hartley, 
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Sikora, and McCoy (2008) found that non-Caucasian children exhibited more challenging 
behaviors than Caucasian children; however they did not control for SES. 
 SIB has been a main focus of research on individuals with ASD and ID since the 1960s 
due to the life-threatening nature of some of the behaviors (Carr, 1977).  The term is used to 
describe any behavior that produces physical damage to the individual’s own body (Tate & 
Baroff, 1966).  Some examples include eye-gouging, head banging, self-scratching, hand biting, 
and skin picking.  Pica is typically considered to be a form of SIB, as it can cause significant 
harm to the individual (Falcomata, Roane, & Pabico, 2007; Roane, Kelly, & Fisher, 2003).  SIB 
often occurs in a repetitive manner leading to debilitation, disfigurement, or in extreme cases—
death (Rojahn, Schroeder, & Hoch, 2008).  Researchers have hypothesized that there is a 
biological etiology of SIB, but there is no definitive explanation at present (Matson & LoVullo, 
2008).  SIBs are currently conceptualized in terms of a functional assessment and then treated 
with behavioral techniques.   
 Aggression is the most common challenging behavior among children with ASD, 
occurring at a rate of between 15% and 68% (Kanne & Mazurek, 2011; Lecavalier, 2006; 
Mazurek, Kanne, & Wodka, 2013).  This potentially dangerous behavior is also the most 
common reason that caregivers seek behavioral or psychotropic treatment for individuals with 
ASD (Parikh, Kolevzon, & Hollander, 2008; Tsakanikos, Costello, Sturmey, & Bouras, 2007).  
Numerous explanations have been offered to account for the high rate of aggression among these 
individuals, including sleep problems (Chervin, Dillon, Archbold, & Ruzicka, 2003) and sensory 
impairments (Shochat, Tzischinsky, & Engel-Yeger, 2009).  In children with ASD, aggression 
serves as a functional behavior that manipulates their environment and is often inadvertently 
reinforced by their caregivers (Foxx & Meindl, 2007).  For example, when a child acts 
 45 
 
aggressively towards a peer at school, the child gets attention from the teacher, principal, and his 
parents.  Tantrum behavior, which can include kicking, screaming, and throwing objects, is often 
grouped under the broader category of aggression (Matson, 2009).  Both tantrum behavior and 
other forms of aggression appear to be primarily maintained by attention (Dawson, Matson, & 
Cherry, 1998). 
 Stereotyped behaviors are considered to be the least problematic of the challenging 
behaviors as they rarely result in injury or damage (Matson, Benavidez, Compton, Paclawski, & 
Baglio, 1996).  However, it is important to note that stereotypic behavior can interfere with skill 
acquisition and has been hypothesized to be a pre-cursor to SIB (Morrison & Rozales-Ruiz, 
1997; Oliver, Murphy, & Corbett, 1987).  Examples of stereotypies are repetitive vocalizations, 
rocking body, heel and toe walking, rubbing body parts, spinning body, hand flapping, and hand 
or finger posturing.  Overall, stereotypic behaviors are highly heterogeneous and occur in 
individuals with ASD of all ages (Cunningham & Schreibman, 2008; Smith & Van Houten, 
1996).  At present, they are the only challenging behavior that is included in the diagnostic 
criteria for ASD (APA, 2013) and stereotyped behavior is more common in lower functioning 
individuals (Matson, Kiely, & Bamburg, 1997; Rojahn, Matlock, & Tasse, 2000).  The most 
commonly mentioned maintaining variable for stereotypy is self-stimulation (i.e., automatic 
reinforcement); however, it can occur for other reasons (Rapp & Vollmer, 2005; Rogers & 
Oznoff, 2005). 
1.8 Assessing Comorbidity 
 As previously stated, when individuals are diagnosed with ASD this is typically the 
primary disorder and all other conditions would be considered secondary.  However, regardless 
of their secondary status, comorbid disorders often require tailored treatments above and beyond 
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the standard behavioral treatments for the core symptoms of ASD (Matson & Nebel-Schwalm, 
2007).  Assessment of comorbidity in this population has been problematic for clinicians as the 
majority of measures were developed for use with typically developing children (Leyfer et al., 
2006).  In many instances, these measures are insufficient to truly determine if the child’s 
symptoms are due to a comorbid disorder or better accounted for by symptoms of ASD.  Thus, 
researchers have worked to develop measures that are tailored to the ASD population, but still 
screen for a variety of emotional and behavioral concerns.  Examples of specific assessment 
scales are provided in more detail in this section. 
 The Child Behavior Checklist (CBCL) was originally developed in the 1970s by Thomas 
Achenbach as a broadband screener of psychopathology in school-aged children.  He developed 
this scale as a standardized method for parents to quickly report on observable behaviors that 
may be problematic (Achenbach, 1978).  It served as an expansion upon the Behavior Problem 
Checklist (Achenbach, 1966; Quay & Peterson, 1967), which was designed for research 
purposes.  The CBCL reflected diagnostic changes that allowed for the diagnosis of a larger 
number of psychological disorders in children, as prior to the publication of the DSM-II (APA, 
1968) the only childhood disorders were adjustment reaction of childhood and childhood 
schizophrenia (Achenbach, 1978).   
 The most recent version of the CBCL (Achenbach & Rescorla, 2001) has been evaluated 
in multiple child populations for diagnostic validity.  One of these populations was children with 
ASD, especially those who are higher functioning (i.e., IQ > 70).  Biederman and colleagues 
(2010) investigated the effectiveness of the CBCL clinical scales in discriminating between 
children with and without ASD.  They found that children with ASD consistently exhibited 
elevations on the Withdrawn/Depressed, Social Problems, and Thought Problems scales.  Ooi, 
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Rescorla, Ang, Woo, and Fung (2011) reported similar findings from their study that compared 
children with ADHD, children with ASD, typically developing children, and children who were 
referred but did not receive a diagnosis.  They constructed an ASD scale that consisted of nine 
items from those three subscales of the CBCL.  Further evidence is needed to evaluate the 
psychometrics of a possible ASD clinical scale; however, elevations on those three subscales 
may indicate to clinicians that the child needs further assessment to rule out a possible ASD.   
 In practice, the CBCL is often used to assess for possible comorbid disorders in children 
already diagnosed with ASD.  Pandolfi, Magyar, and Dill (2012) evaluated the psychometric 
properties of the measure in 122 children with ASD.  They found that the CBCL had good 
sensitivity, but lacked specificity in detecting comorbid psychopathology in this population.  
Thus, the results of the CBCL should be used in conjunction with data from clinical interview 
and further assessment when diagnosing comorbid disorders in children with ASD.  The 
psychometric properties of the CBCL are discussed in more detail in the description of the 
current study. 
 The Behavior Assessment System for Children, Second Edition (BASC-2; Reynolds & 
Kamphaus, 2004) was also developed to assess for problem behaviors and adaptive skills in 
children.  The researchers included children and adolescents diagnosed with ASD in their initial 
sample, and the scale has since been commonly used with children with ASD.  The measure 
provides nine clinical scales (i.e., aggression, anxiety, attention problems, atypicality, conduct 
problems, depression, hyperactivity, somatization, and withdrawal) and five adaptive scales (i.e., 
functional communication, activities of daily living, adaptability, leadership, and social skills).  
The scales load onto four composites: Behavioral Symptoms Index, Adaptive Skills, 
Externalizing Problems, and Internalizing Problems.  The parent report form of the BASC-2 had 
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internal consistency scores ranging from .90 to .95 (Reynolds & Kamphaus, 2004).  Furthermore, 
alpha coefficients for the different scales had a mean of .84.  The BASC-2 demonstrated 
convergent validity with the CBCL.  
 Volker and colleagues (2010) utilized the BASC-2 with a population of children with 
high-functioning ASD.  These children were significantly elevated on the Atypicality, 
Withdrawal, and Behavioral Symptoms Index in comparison to typically developing children.  
When evaluating a broader ASD group with the BASC-2, Mahan and Matson (2011a) found that 
children with ASD scored significantly higher on all clinical subscales and composites than 
typically developing children.  Likewise, the children with ASD scored significantly lower on 
the adaptive subscales and composite.   
 Contrary to the BASC-2 and CBCL, the Autism Comorbidity Interview-Present and 
Lifetime Perspective (ACI-PL; Leyfer et al., 2006) was developed to specifically assess for 
psychopathology in children with ASD.  The authors of the measure modified the Kiddie 
Schedule for Affective Disorders and Schizophrenia (Puig-Antich & Chambers, 1978) to reflect 
the discrepancies in the presentation of comorbid symptoms in this population.  The authors 
emphasized the importance of establishing a baseline for each child and then asking the parents 
about changes from baseline that might indicate the presence of a comorbid disorder (Leyfer et 
al., 2006).  The interview also allows for flexibility in the questioning to make the measure more 
applicable to the cognitive capacities of the child (i.e., only probing about guilt in higher 
functioning individuals).  The psychometric properties of this measure are still unknown at this 
time.       
 The Developmental Behavior Checklist (DBC; Einfeld & Tonge, 1992) was developed to 
assess behavioral and emotional disturbances in children with ID and developmental disabilities.  
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The parent report measure produces a Total Behavior Problem Score and subscale scores 
(disruptive, antisocial, self-absorbed, communication disturbance, anxiety, and social relating).  
The measure has been shown to have high inter-rater reliability, test-retest reliability, and 
internal consistency for identifying comorbid disorders in children with ID (Einfeld & Tonge, 
1995).  The DBC also has an Autism Screening Algorithm consisting of 26 items that can be 
utilized for diagnostic purposes.  Bereton, Tonge, Mackinnon, and Einfeld (2002) evaluated 180 
children with ASD and 180 matched controls using the algorithm and found that a cutoff score of 
17 could reliably discriminate between children with ASD and controls.  However, Witwer and 
Lecavalier (2007) found that the Autism Screening Algorithm had poor specificity, especially in 
instances where the child exhibited a high number of challenging behaviors. 
 The Autism Spectrum Disorders-Child Version (ASD-C; Matson & Gonzalez, 2007a,b,c) 
was developed to be a cost-efficient screen for atypically developing children with possible 
ASD.  It is the first measure to be specifically designed to assess comorbid emotional and 
behavioral disorders in children with ASD.  The assessment battery serves multiple purposes: 1) 
assesses symptoms of ASD; 2) assesses for possible comorbid disorders; 3) identifies 
challenging behavior; and 4) monitors changes in presentation over time.  Specific items for the 
measure were generated from a comprehensive literature review and incorporation of diagnostic 
standards.  The items were modified after initial psychometric evaluation to increase the 
reliability and validity of the measure.  Both typically developing children and children with 
ASD were included in the standardization sample to allow for a broader application.  The 
psychometric properties of this assessment battery are discussed in more detail in the description 
of the current study. 
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CHAPTER 2. PURPOSE 
 In many settings, especially outpatient clinics and the school system, comprehensive 
clinical evaluations are not always feasible.  Thus, parent rating scales are the most commonly 
used measures of child psychopathology in current practice (Hunsley & Mash, 2008).  This 
represents a shift from the extensive test batteries that were previously employed by 
psychologists working with children, which consisted of intelligence testing, achievement 
testing, projective personality tests, and specific measures of psychopathology (Mash & Hunsley, 
2004).  These lengthy evaluations were time and cost intensive, which made such testing 
unattainable for many families with children at risk for developmental disabilities, behavioral, 
and affective disorders (Percevic, Lambert, & Kordy, 2004).  Data from the National Survey of 
American Families revealed that only 21% of children in need of services were actually being 
seen by mental health professionals (Kataoka, Zhang, & Wells, 2002).  Newer, broadband 
measures have been developed to allow clinicians to effectively screen for a variety of 
psychological disorders as the first step in a comprehensive assessment (Mash & Hunsley, 2005).  
These measures increase the likelihood that children, especially from underserved areas, will 
receive necessary mental health services.   
 The first psychometrically sound broadband measure of psychopathology in children was 
the CBLC (Achenbach, 1978).  The revised versions of this measure are still frequently 
administered to parents as a brief screen for a range of psychological and behavioral problems.  
In cases where the child is suspected to have a developmental disability, the child should also be 
administered measures that are tailored to the ASD population.  Thus, the ASD-C (Matson & 
Gonzalez, 2007a,b,c) was developed to address the need for a screening measure for symptoms 
of ASD, comorbid disorders, and challenging behavior in children with possible ASD.  To date, 
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numerous publications have examined the reliability and validity of both of these measures, but 
none have compared the two measures.   
The goal of the study was to evaluate the construct validity of both measures.  Both the 
broadband (e.g., Externalizing and Internalizing) and narrowband (e.g., ASD-C Worry/Depressed 
and CBCL Anxious/Depressed) scales of the ASD-C and CBLC were examined to evaluate 
similarities and differences in how these measures assess behaviors.  Additionally, the diagnostic 
accuracy of various subscales and composites from the ASD-C and CBCL was evaluated.  As 
broad screeners for psychopathology, the ability of these measures to correctly identify disorders 
is critical.  Early identification precipitates the best long-term outcomes for children with 
developmental disabilities or psychological disorders.  Numerous studies have documented that 
low SES is a risk factor for psychological disorders in children (Bringewatt & Gershoff, 2010; 
Knitzer, 1996; McLearn, Knitzer, & Carter, 2007).  Thus, establishing the validity of these 
inexpensive screening measures helps to provide services to children and their families whom 
face numerous barriers to care.  These measures are especially useful for clinicians who are not 
specifically trained in identifying developmental disabilities and comorbid disorders.  They allow 
a pediatrician or teacher to identify that a child is at risk based on his elevation on a particular 
subscale.  This child can then be referred to a psychologist or psychiatrist for further evaluation.  
Evaluating the diagnostic validity of these measures ensures their utility as low-cost broadband 
screeners of psychopathology in children.     
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CHAPTER 3. METHOD 
3.1 Participants 
Participation in this study was based on participation in a larger research study, so the 
data had been collected over a period of multiple years.  Participants for this study were 114 
children who received a developmental disability, gifted, or psychoeducational assessment at a 
university clinic in the southeastern United States between the ages of 6 and 16.  A power 
analysis program, G*Power (Erdfelder, Faul & Buchner, 1996), was utilized to determine the 
number of participants needed to have enough power to run this study.  When looking at a two-
tailed correlation utilizing Spearmen’s Rho with a medium effect size of .30, a total sample size 
of 84 was needed.  The standard in the behavioral sciences is to set the significance level at α 
=.05, which sets the power at .80 (Hinkle, Wiersma, & Jurs, 2003).  A two-tailed test was 
utilized, because both positive and negative correlations could have been significant.  In order to 
be included in the current study, parents/guardians of participants must have completed the 
CBCL and ASD-C.  Participants were excluded if more than 3 items were missing on either of the 
measures.  Additionally, participants were excluded if there was demographic information 
missing (i.e., age, gender, race).   
The sample consisted of 74 males (64.9%) and 40 females (35.1%).  Participants ranged 
in age from 6-16 years old (M = 9.72, SD = 2.76).  The majority of participants self-identified as 
White, non Hispanic (81.6%).  Table 1 presents the demographic characteristics of the 
participants.  Overall, 14 children were diagnosed with ASD, 29 children had no diagnosis, and 
71 children were diagnosed with some form of psychopathology yet still typically developing.  
Table 2 presents a breakdown of the children with psychopathology without ASD.  Diagnoses of 
psychopathology were made using a psychoeducational battery that included the Anxiety 
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Disorders Interview Schedule for DSM IV – Child and Parent version (Silverman & Albano, 
1996), normative child, parent, and teacher rating scales (e.g., Achenbach scales; Achenbach & 
Rescorla, 2001; Conners’ scales; Conners, 1997), and standardized intellectual and achievement 
tests.  
Table 1 
Demographic Characteristics by Diagnostic Group (N=114) 
Demographic 
Characteristics 
ASD 
(n=14) 
Non-ASD  
(n=29) 
Psychopathology 
(n=71) 
Age (in years)     
     Mean (SD) 9.93 (3.22) 9.66 (3.00) 9.70 (2.60) 
     Range 6-16 6-16 6-15 
Gender, %    
     Male 92.9% 69.0% 57.7% 
     Female 7.1% 31.0% 42.3% 
Race/Ethnicity, %    
     Caucasian 85.7% 82.8% 80.3% 
     African-American 7.1% 13.8% 14.1% 
     Hispanic 7.1% 0% 1.4% 
     ‘Other’ 0% 3.4% 4.2% 
 
 
Table 2 
Diagnoses for Children in the Psychopathology Group (N=71) 
 
Psychological Diagnoses   
Anxiety Disorder  33.8% 
Mood Disorder 2.8% 
Attention-Deficit/Hyperactivity Disorder 33.8% 
Oppositional Defiant Disorder 14.1% 
Other 15.5% 
 
3.2 Measures 
3.2.1 Child Behavior Checklist 
The Child Behavior Checklist (CBCL; Achenbach & Rescorla, 2001) is a parent rating 
scale that assesses for a broad range of possible psychological disorders in children and 
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adolescents.  The measure is available in two forms for different age groups.  Only the School 
Age form for children 6-18 years old was utilized in the current research.  The scale consists of 
112 items that were rated by the parents and/or guardians on how true the statement is about their 
children: 0 = “Not true,” 1 = “Somewhat or Sometimes True,” and 2 = “Very True or Often 
True.”  The informants were prompted to assess their children’s behavior over the past 6 months.  
The scale requires between 10 and 20 minutes to complete, with the discrepancy reflecting how 
quickly the informant can read each item.  In this study, the measure was computer scored by 
doctoral level graduate students working under the supervision of a licensed clinical 
psychologist.  The computer scoring program produces norm-referenced T-scores for symptom 
scales, DSM-oriented syndrome scales, and behavior problem scales.  However, raw scores were 
utilized for the purposes of this study to allow for comparison with the ASD-C. 
A confirmatory factor analysis produced an eight-factor structure (i.e., 
Anxious/Depressed, Withdrawn/Depressed, Somatic Complaints, Social Problems, Thought 
Problems, Attention Problems, Rule-Breaking Behavior, and Aggressive Behavior) for the 
symptom scales (Achenbach & Rescorla, 2001).  All eight subscales were considered for the 
current research.  The behavior problem scales consist of Internalizing Problems, Externalizing 
Problems, and Total Problems, of which the Internalizing and Externalizing composites were 
also utilized in the current study.  The six DSM-oriented syndrome scales and the Competence 
scales were not considered in the current analyses. 
The CBCL has been shown to have excellent psychometric properties.  The inter-rater 
reliability was .96, test-retest reliability was .95, and internal consistency ranged from .78 to .97 
(Achenbach & Rescorla, 2001).  The test creators used structural equation modeling to assess the 
effect of demographic variables on syndrome ratings.  They found a significant effect of SES, 
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such that children of lower SES had higher problem scores.  To assess the construct validity of 
the measure, researchers compared DSM-IV diagnoses and significant syndrome scale elevations.  
Kappa coefficients ranged from .27 for the Anxious/Depressed sale and diagnoses of Anxiety 
disorder to .80 for the Attention Problems scale and diagnoses of ADHD (Achenbach & 
Rescorla, 2001).  To establish convergent and discriminant validity, the CBCL was compared to 
the Conners scales (Conners, 1997) and the BASC (Reynolds & Kamphaus, 1992) with results 
indicating that the measures assessed similar underlying constructs.     
The ASD scale is an unofficial subscale of the CBCL comprised of 9 items: 1. Acts too 
young for his/her age; 25. Doesn’t get along with other kids; 29. Fears certain animals, 
situations; 42. Would rather be alone than with others; 46. Nervous movements or twitching; 66. 
Repeats certain acts over and over; 79. Speech problems; 84. Strange behavior; 111. Withdrawn, 
doesn’t get involved with others (Ooi et al., 2011).  This was included in this study for the 
purposes of assessing the diagnostic accuracy of the CBCL in identifying ASD.            
3.2.2 Autism Spectrum Disorders – Child Version 
The Autism Spectrum Disorders – Child Version (ASD-C) consists of three separate 
scales that can be administered in combination to provide a comprehensive assessment of core 
symptoms, comorbid disorders, and behavior problems in children with ASD.  The Autism 
Spectrum Disorder –Diagnostic Child Version (ASD-DC; Matson & Gonzalez, 2007c) consists 
of 40 items that assess symptoms of ASD in children from ages 2-16 years.  Informants, who 
were the parent and/or guardian of the child, rated the items on a 3-point scale where 0 = “not 
different; no impairment,” 1 = “somewhat different; mild impairment,” and 2 = “very different; 
severe impairment.”  The measure has been shown to have good psychometrics with test-retest 
and inter-rater reliability at .77 and .67 respectively (Matson, Gonzalez, Wilkins, & Rivet, 2007).  
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Additionally, the ASD-DC was able to distinguish between children with atypical development 
and no diagnosis at a rate of 84.3% and between atypical development and ASD at a rate of 
87.8% (Matson, Gonzalez, & Wilkins, 2009).  Matson, Boisjoli, and Dempsey (2009) established 
a four factor structure for the items: social relationships, nonverbal communication/socialization, 
verbal communication, and restricted interests/insistence on sameness.     
The convergent validity of the ASD-DC was examined utilizing the Childhood Autism 
Rating Scales (CARS; Schopler, Reichler, & Rochen-Renner, 1988) and the Autism Diagnostic 
Interview Revised (ADI-R; Lord, Rutter, & LeCouteur, 1994).  The CARS and ASD-DC had all 
significant correlations for related factors ranging from .37 to .68 and overall convergent validity 
was moderately high, r = .54 (Matson, Mahan, Hess, Fodstad, & Neal, 2010).  Furthermore, the 
ASD-DC was found to have higher sensitivity and specificity, 76.5% and 95.0% respectively, 
than the CARS (58.8% and 85.0% respectively).  Likewise, all correlations between the ASD-DC 
and ADI-R were statistically significant ranging from .48 to .61 and confirming convergent 
validity (Matson, Hess, Mahan, & Fodstad, 2010).  In addition, the ASD-DC had a sensitivity of 
73% and specificity of 67%, while the ADI-R had a sensitivity of 46%, but a specificity of 100%. 
The Autism Spectrum Disorders-Comorbidity Child (ASD-CC; Matson & Gonzalez, 
2007b) was developed to measure commonly comorbid symptoms in children with ASD.  The 
measure consists of 39 items that are rated by the caregiver as 0 = “not a problem or impairment; 
not at all”; 1= “mild problem or impairment”; 2 = “severe problem or impairment”; or X= “does 
not apply or don’t know.”  Specific items screen for conditions including ADHD, depression, 
eating disorders/difficulties, OCD, specific phobias, tic disorders, and conduct disorder.  The 
results of an exploratory factor analysis revealed a seven-factor structure: Tantrum Behavior, 
Repetitive Behavior, Worry/Depressed, Avoidant Behavior, Under-Eating, Conduct, and Over-
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Eating (Matson, LoVullo, Rivet, & Boisjoli, 2009).  The internal consistencies of the factors 
ranged from .70 to .86 (Matson et al., 2009).  The measure also demonstrated convergent and 
discriminant validity with the BASC-2 (Matson et al., 2009).  There are established cut-off scores 
for the ASD-CC that categorize a score as either “no/minimal impairment,” “moderate 
impairment,” or “severe impairment” (Thorson & Matson, 2012).  These cut-offs allow the 
measure to be used more readily as an initial screening instrument for psychopathology in 
children with ASD.     
The Autism Spectrum Disorders-Behavior Problems Child (ASD-BPC; Matson & 
Gonzalez, 2007a) was designed to identify common problem behaviors in children with ASD.  
Specific items target SIB, aggression, pica, stereotypies, and property destruction.  Caregivers 
rate each behavior as 0 = “not different; no impairment,” 1 =”somewhat different; mild 
impairment,” or 2 = “very different; severe impairment.”  An exploratory factor analysis 
revealed a two-factor structure with Externalizing Behavior accounting for 36.72% of variance 
and Internalizing Behavior accounting for 9.94% of variance (Matson, Gonzalez, & Rivet, 2008).  
Mean inter-rater reliability was .49 with 92% agreement, while mean test-retest reliability was 
.64 with 92% agreement.  Intercorrelations between items ranged from .04 to .63 with a mean of 
.32.  Moreover, the ASD-BPC had an internal consistency of α = .90.  The ASD-BPC has been 
demonstrated to have convergent and discriminant validity with the BASC-2 (Mahan & Matson, 
2011b).  The aggression, hyperactivity, and atypicality subscales of the BASC-2 were all 
significantly correlated with the ASD-BPC externalizing scale, r = .61, r = .52, and r = .48, 
respectively.  The atypicality subscale was also significantly correlated with the ASD-BPC 
internalizing scale, r = .51.           
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3.3 Procedure 
 Informed consent from the parents and/or guardians and assent from the participants 
(when developmentally appropriate) were obtained prior to enrollment in the study.  The CBCL 
and ASD-C were completed by the parents and/or guardians of the participants.  Directions were 
printed clearly on all measures and the informants were encouraged to discuss any questions or 
issues with their clinicians when they arose.  Graduate clinicians trained in the administration 
and scoring procedures for all measures made follow-up calls when necessary to fill in missing 
items.  The measures were scored by the clinicians and entered into a larger research database.  
Supervision was provided throughout the data collection process by a licensed clinical 
psychologist.  The data used in this study was collected from 2008 to the present.  The study was 
approved by the Louisiana State University Institutional Review Board. 
3.4 Statistical Analyses 
 Prior to calculating statistical findings, item content was compared between the CBCL 
and ASD-C composites and subscales to demonstrate convergent validity.  Items were considered 
a match if they had the same operational definition or if the item represented a closely related 
behavior to an item from the other measure when there was not an exact match. 
 To assess the convergent and divergent validity of the CBCL and ASD-C a correlational 
matrix similar to the Multitrait-Multimethod Matrix developed by Campbell and Fiske (1959) 
was employed.  The content analysis helped guide the selection of scales and subscales to 
compare for assessing convergent validity.  Spearman’s Rho was utilized instead of Pearson’s R, 
because the sample had an abnormal distribution.  The distribution was specifically analyzed 
using the Kolmogorov-Smirnov (KS) tests of normality for all subscales and scales utilized in 
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this study and found to violate assumptions of normality.  Bivariate correlations were calculated 
using p < .05 to determine significance.   
 To further assess the construct validity of both measures, receiver operating characteristic 
(ROC) curves were generated by plotting the relationship of the true positivity (sensitivity) and 
the false positivity (1 - specificity) of the subscales.  ROC analyses result in an area under the 
curve (AUC), which indicates the degree to which the subscale predicted a binary classification 
(e.g., with or without disorder) (Hanley & McNeil, 1982).  For the current study, AUC values 
were interpreted according to the following designations: .50-.70 = poor, .70-.80 = fair, .80-.90 = 
good, and .90-1.00 = excellent.  Subscales and composites from the CBCL and ASD-C were 
analyzed using ASD, Anxiety Disorder, ADHD, and ODD as the positive actual states. 
3.5 Hypotheses 
Based on the existing literature on the validity of the both the CBCL and ASD-C 
separately, several predictions were made in regards to the outcomes of this study.  First, 
convergent validity would be confirmed by a high level of correlation between similar subscales.  
The Withdrawn/Depressed, Social Problems, and Thought Problems scales from the CBCL were 
hypothesized to correlate highly with overall ASD severity as measured by the ASD-DC.  
Children with high scores on the ASD-DC were predicted to have higher scores on the three 
subscales than children with none or only a small number of ASD symptoms.  It was further 
expected, that the Worry/Depressed subscale of the ASD-CC would correlate positively with the 
Anxious/Depressed and Internalizing Problems subscales of the CBCL.  The Avoidant subscale 
of the ASD-CC would correlate positively with the Withdrawn/Depressed and Internalizing 
Problems subscales of the CBCL.  The Tantrum Behavior subscale of the ASD-CC was expected 
to correlate positively with the Aggressive Behavior and Externalizing Problems subscales of the 
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CBCL.  The Conduct subscale of the ASD-CC was likewise expected to correlate positively with 
the Rule-Breaking Behavior and Externalizing Problems subscales of the CBCL.  Further, the 
Externalizing subscale of the ASD-BPC was expected to correlate positively with the 
Externalizing Problems subscale of the CBCL.  Second, discriminant validity would be 
confirmed by negative or low correlations between dissimilar subscales.  The Internalizing 
Problems subscale of the CBCL was hypothesized to demonstrate discriminant validity with the 
Internalizing and Externalizing subscales of the ASD-BPC.  Additionally, the Repetitive 
Behaviors subscale of the ASD-CC would demonstrate divergent validity with the Internalizing 
Problems subscale of the CBCL.   
As for the diagnostic accuracy of the measures, the Diagnostic Total (i.e., sum of items 
from ASD-DC) of the ASD-C was hypothesized to accurately predict which participants were 
diagnosed with ASD by the licensed psychologist.  Second, it was predicted that the 
Withdrawn/Depressed, Social Problems, and Thought Problems subscales from the CBCL would 
accurately identify children diagnosed with ASD.  The ASD scale from the CBCL was also 
predicted to accurately identify children with ASD. 
Furthermore, the Anxious/Depressed subscale and Internalizing composite of the CBCL 
were predicted to accurately identify children diagnosed with an Anxiety Disorder.  Likewise the 
Worry/Depressed subscale of the ASD-C was predicted to accurately identify children diagnosed 
with an Anxiety Disorder.  As for ADHD, the Attention Problems subscale and Externalizing 
composite of the CBCL were predicted to correctly identify children with the disorder.  Further, 
the Rule-Breaking Behavior subscale of the CBCL and the Conduct and Tantrum Behavior 
subscales of the ASD-C were predicted to correctly identify children with ODD. 
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CHAPTER 4. RESULTS 
 Content analysis revealed that operationally similar items from the ASD-C and CBCL 
were significantly correlated.  Refer to Table 3 for a breakdown of the correlations between 
items.  Convergence was demonstrated for all the predicted pairings of subscales from the two 
measures.  There was a significant positive correlation between the Diagnostic Total of the ASD-
DC and the Withdrawn/Depressed subscale of the CBCL, ρ = .685, p <.01.  The Diagnostic Total 
of the ASD-DC was also positively and significantly correlated with the Thought Problems 
subscale of the CBCL, ρ = .534, p <.01, and the Social Problems subscale of the CBCL, ρ = .697, 
p <.01.  There was a significant positive correlation between the Worry/Depressed subscale of 
the ASD-CC and the Anxious/Depressed subscale of the CBCL, ρ = .562, p <.01.  Additionally, 
the Worry/Depressed subscale of the ASD-CC was significantly correlated with the 
Withdrawn/Depressed subscale of the CBCL, ρ = .615, p <.01.  The Conduct scale of the ASD-
CC was significantly correlated with the Rule-Breaking Behavior subscale of the CBCL, ρ = 
.569, p <.01.  Likewise, the Tantrum subscale of the ASD-CC was significantly correlated with 
the Aggressive Behavior subscale of the CBCL, ρ = .764, p <.01. 
Table 3 
Correlations between Individual Items on the ASD-C and CBCL 
 
CBCL item ASD-C item Spearman’s 
rho 
#65. Refuses to talk ASD-DC # 1. Communication skills .433* 
#79. Speech problems ASD-DC # 1. Communication skills .439* 
#50. Too fearful or anxious ASD-CC #36. Experiences excessive 
worry or concern 
.500* 
#65. Refuses to talk ASD-DC #4. Verbal communication .369* 
#79. Speech problems ASD-DC #4. Verbal communication .477* 
#24. Doesn’t eat well ASD-DC #5. Prefers food of a certain 
texture or smell 
.230** 
#25. Doesn’t get along well 
with other kids 
ASD-DC # 8. Social interaction with 
others his/her age 
.315* 
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(Table 3 continued)   
CBCL item ASD-C item Spearman’s 
rho 
#48. Not liked by other kids ASD-DC # Social interaction with 8 
others his/her age 
.310* 
#65. Refuses to talk ASD-DC #10. Use of language in 
conversations with others 
.343* 
#79. Speech problems ASD-DC #10. Use of language in 
conversations with others 
.523* 
#69. Secretive, keeps things to 
self 
ASD-DC #11. Shares enjoyment, 
interests, or achievements with others 
.057 
#25. Doesn’t get along well 
with other kids 
ASD-DC #12. Ability to make and keep 
friends 
.476* 
#48. Not liked by other kids ASD-DC #12. Ability to make and keep 
friends 
.391* 
#42. Would rather be alone 
than with others 
ASD-DC # 13. Interest in participating in 
social games, sports, and activities 
.618* 
#111. Withdrawn, doesn’t get 
involved with others 
ASD-DC # 13. Interest in participating in 
social games, sports, and activities 
.706* 
#65. Refuses to talk ASD-DC #18. Communicates effectively .461* 
#79. Speech problems ASD-DC #18. Communicates effectively .434* 
#25. Doesn’t get along well 
with other kids 
ASD-DC #35. Socializes with other 
children 
.436* 
#42. Would rather be alone 
than with others 
ASD-DC #35. Socializes with other 
children 
.605* 
#48. Not liked by other kids ASD-DC #35. Socializes with other 
children 
.317* 
#14. Cries a lot  ASD-CC #1. Easily becomes upset .320* 
#53. Overeating ASD-CC #2. Eats too much .574* 
#14. Cries a lot  ASD-CC #5. Crying .322* 
#24. Doesn’t eat well ASD-CC #6. Will eat only certain foods .350* 
#21. Destroys things belonging 
to his/her family or others 
ASD-CC #7. Destroys others’ property .635* 
#106. Vandalism ASD-CC #7. Destroys others’ property .428* 
#43. Lying or cheating ASD-CC #9. Lies to obtain goods or 
favors 
.423* 
#66. Repeats certain acts over 
and over; compulsions 
ASD-CC #11. Engages in repetitive 
behaviors for no apparent reason or to 
reduce stress 
.512* 
#22. Disobedience at home ASD-CC #12. Compliance with demands .503* 
#23. Disobedience at school ASD-CC #12. Compliance with demands .407* 
#28. Breaks rules at home, 
school, or elsewhere 
ASD-CC #12. Compliance with demands .464* 
#24. Doesn’t eat well ASD-CC #13. Has a poor appetite .547* 
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(Table 3 continued)   
CBCL item ASD-C item Spearman’s 
rho 
#9. Can’t get his/her mind off 
certain thoughts; obsessions 
ASD-CC #14. Has persistent or recurring 
thoughts that cause distress 
.310* 
#24. Doesn’t eat well ASD-CC #16. Eats too little .579* 
#111.Withdrawn, doesn’t get 
involved with others 
ASD-CC # 17. Withdraws or removes 
him/her self from social situations 
.767* 
#76. Sleeps less than most kids ASD-CC #18. Has trouble sleeping .512* 
#77. Sleeps more than most 
kids during day and/or night 
ASD-CC #18. Has trouble sleeping .140 
#100. Trouble sleeping ASD-CC #18. Has trouble sleeping .696* 
#21. Destroys things belonging 
to his/her family or others 
ASD-CC #19. Damages property .661* 
#106. Vandalism ASD-CC #19. Damages property .414* 
#14. Cries a lot  ASD-CC #22. Tearful or weepy .384* 
#52. Feels too guilty ASD-CC #23. Feelings of worthlessness 
or excessive guilt 
.266* 
#35. Feels worthless or inferior ASD-CC #23. Feelings of worthlessness 
or excessive guilt 
.484* 
#4. Fails to finish things he/she 
starts 
ASD-CC #26. Finishes assigned tasks .428* 
#95. Temper tantrums or hot 
temper 
ASD-CC #28. Easily becomes angry .632* 
#95. Temper tantrums or hot 
temper 
ASD-CC #30. Tantrums .588* 
#10. Can’t sit still, restless, or 
hyperactive 
ASD-CC #31. Fidgets or squirms .611* 
#54. Overtired without good 
reason 
ASD-CC #32. Low energy or fatigue .766* 
#86. Stubborn, sullen, or 
irritable 
ASD-CC #35. Irritable mood .474* 
#112. Worries ASD-CC #36. Experiences excessive 
worry or concern 
.513* 
#50. Too fearful or anxious ASD-CC #36. Experiences excessive 
worry or concern 
.500* 
 
*Correlation is significant at p < .01 (2 tailed) 
**Correlation is significant at p < .05 (2 tailed) 
Contrary to the hypothesized outcomes, subscales that were not predicted to correlate 
(e.g., ASD-C Worry/Depressed and CBLC Rule-Breaking Behavior) were positively and 
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significantly correlated.  Thus, there was no evidence of divergence between the two measures.  
Please refer to Table 4 for the complete Multitrait-Multimethod Matrix.
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Table 4 
Multitrait Multimethod Matrix for Convergent Validity of ASD-C and CBCL 
Note: A/D = CBCL Anxious/Depressed Symptom Scale, W/D = CBCL Withdrawn/Depressed Symptom Scale, SC = CBCL Somatic 
Complaints Symptom Scale, SP = CBCL Social Problems Symptom Scale, TP = CBCL Thought Problems Symptom Scale, AP = 
CBCL Attention Problems Symptom Scale, R-BB = CBCL Rule-Breaking Behavior Symptom Scale, AB = CBCL Aggressive 
Behavior Symptom Scale, IP = CBCL Internalizing Problems Subscale, EP = CBCL Externalizing Problems Subscale, ASD-DC = 
ASD-C Autism Severity Total Score, TB = ASD-C Tantrum Behavior Subscale, RB = ASD-C Repetitive Behavior Subscale, WD = 
ASD-C Worry/Depressed Subscale, A = ASD-C Avoidant Behavior Subscale, CB = ASD-C Conduct Behavior Subscale, EB = ASD-C 
Externalizing Behavior Subscale, IB = ASD-C Internalizing Behavior Subscale 
All correlations were significant at p < .05
Child Behavior Checklist Autism Spectrum Disorder-Child Version 
 A/D W/D SC SP TP AP R-BB AB IP EP ASD-DC TB RB WD AB CB EB IB 
A/D 1                  
W/D .558 1                 
SC .597 .431 1                
SP .542 .607 .590 1               
TP .490 .519 .606 .685 1              
AP .293 .420 .489 .608 .620 1             
R-BB .341 .399 .365 .562 .437 .478 1            
AB .295 .421 .422 .654 .525 .609 .735 1           
IP .893 .776 .788 .692 .651 .458 .433 .434 1          
EP .325 .449 .428 .670 .541 .618 .852 .978 .462 1         
ASD-
DC 
.385 .685 .262 .697 .534 .473 .357 .496 .532 .487 1        
TB .346 .488 .368 .662 .472 .529 .551 .764 .472 .741 .690 1       
RB .312 .441 .405 .629 .564 .612 .456 .616 .456 .600 .613 .646 1      
WD .562 .615 .553 .670 .597 .554 .430 .518 .680 .525 .611 .696 .599 1     
AB .583 .732 .480 .697 .647 .493 .475 .527 .728 .548 .747 .543 .589 .617 1    
CB .191 .362 .237 .550 .404 .489 .569 .709 .318 .704 .605 .756 .624 .546 .502 1   
EB .327 .401 .265 .528 .473 .467 .621 .715 .460 .461 .619 .675 .567 .480 .555 .675 1  
IB .352 .577 .240 .552 .548 .475 .342 .459 .396 .723 .744 .550 .660 .457 .608 .484 .593 1 
 66 
 
ROC curve analyses were conducted with ASD as the positive actual state.  The ROC 
curve analysis for the Diagnostic Total of the ASD-DC resulted in an AUC of .885, which is 
classified as good.  Please refer to Figure 1 for the ROC curve.  As for the CBCL subscales, the 
AUC for the Withdrawn/Depressed subscale was .827, which is classified as good.  Please refer 
to Figure 2 for the ROC curve.  However, the Social Problems (AUC = .790) and Thought 
Problems (AUC = .786) were in the fair range.  Please refer to Figures 3 and 4 for the ROC 
curves.  As for the ASD scale from the CBCL, the AUC was .890, which is classified as good.  
Please refer to Figure 5 for the ROC curve.   
 
 
Figure 1. ROC Curve for ASD-C Diagnostic Total 
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Figure 2. ROC Curve for Withdrawn/Depressed Subscale from CBCL 
 
 
 
Figure 3. ROC Curve for Social Problems Subscale from CBCL 
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Figure 4. ROC Curve for Thought Problems Subscale from CBCL 
 
 
Figure 5. ROC Curve for ASD Scale from CBCL 
ROC curve analyses were also conducted for other diagnostic categories (e.g., Anxiety 
Disorder, ADHD, and ODD).  Using Anxiety Disorder as the positive actual state, the CBCL 
Anxious/Depressed subscale (AUC = .762) and CBCL Internalizing composite (AUC = .718) 
were both determined to be fair at correctly identifying individuals diagnosed with an Anxiety 
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Disorder.  Please refer to Figures 6 and 7 for the ROC curves.  Whereas, the Worry/Depressed 
subscale of the ASD-C had an AUC of .545, which is classified as poor.  Please refer to Figure 8 
for the ROC curve.  Using ADHD as the positive actual state, the CBCL Attention Problems 
subscale (AUC = .637) was found to be poor at identifying children diagnosed with ADHD, 
while the CBCL externalizing composite (AUC = .471) failed to identify children with ADHD 
beyond what would be predicted by chance.  Please refer to Figures 9 and 10 for the ROC 
curves.  Using ODD as the positive actual state, the CBCL Rule-Breaking Behavior (AUC = 
.854) and Aggressive Behavior (AUC = .814) subscales were classified as good.  Please refer to 
Figures 11 and 12 for the ROC curves.  Whereas, the ASD-C Conduct subscale (AUC = .707) 
was classified as fair and the ASD-C Tantrum Behavior subscale (AUC = .652) was classified as 
poor.  Please refer to Figures 13 and 14 for the ROC curves. 
 
Figure 6. ROC Curve for Anxious/Depressed Subscale from CBCL 
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Figure 7. ROC Curve for Internalizing Composite from CBCL 
 
 
Figure 8. ROC Curve for Worry/Depressed Subscale from ASD-C 
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Figure 9. ROC Curve for Attention Problems Subscale from CBCL 
 
 
 
Figure 10. ROC Curve for Externalizing Problems Composite from CBCL 
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Figure 11. ROC Curve for Rule-Breaking subscale from CBCL 
 
 
 
Figure 12. ROC Curve for Aggressive Behavior Subscale from CBCL 
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Figure 13. ROC Curve for Conduct Subscale from CBCL 
 
 
Figure 14. ROC Curve for Tantrum Behavior Subscale from CBCL 
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CHAPTER 5. DISCUSSION 
 The rationale behind the present study was to examine the construct validity of the 
Autism Spectrum Disorder – Child Version and the Child Behavior Checklist in children with 
and without ASD.  Parent rating scales are time and cost effective measures that are commonly 
used to screen for psychological disorders (Hunsley & Mash, 2008).  They allow clinicians to 
provide affordable services to children who may otherwise be unable to access mental health 
care due to financial constraints (Kataoka, Zhang, & Wells, 2002).  The CBCL is one of the most 
widely used broadband screeners of psychopathology in clinical practice.  However, the measure 
was developed for typically developing children.  In cases where the child is suspected to have a 
developmental disability, the child should also be administered measures that are tailored to the 
ASD population.  Thus, the ASD-C was specifically developed to address the need for a 
screening measure for core symptoms of ASD, related disorders, and challenging behaviors in 
children with possible developmental disabilities.  As broadband screeners for psychopathology, 
the ability of these measures to correctly identify disorders is critical.  Thus, establishing the 
validity of these inexpensive screening measures helps to provide mental health services to a 
broader range of children and their families.       
Based on the results of the Multitrait-Multimethod Matrix, the two measures were shown 
to demonstrate convergent validity.  There were significant positive correlations both between 
individual items with similar operational definitions and subscales assessing similar constructs.  
Contrary to hypotheses, operationally dissimilar subscales did not demonstrate divergent 
validity.  This could potentially be attributed to the high rates of concurrent comorbidity among 
the participants.  Previous researchers found that between 20% to 25.5% of children with a 
psychological disorder also met criteria for one or more concurrent diagnoses (Costello et al., 
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2003; Merikangas et al., 2010).  Further, children with ASD have even higher rates of 
comorbidity with estimates as high as 70% (Simonoff et al., 2008).  With these high rates of 
psychiatric symptoms, the children included in this study likely elevated on subscales measuring 
dissimilar disorders (e.g., exhibited symptoms of anxiety and oppositional behavior).  
Conversely, the parents of children without any psychological disorders (i.e., controls) likely had 
no or few endorsements on items.   
 The measures were also evaluated for diagnostic validity for ASD, ADHD, Anxiety 
Disorder, and ODD.  The Diagnostic Total of the ASD-C, Withdrawn/Depressed subscale of the 
CBCL, and ASD scale for the CBCL were determined to be good at identifying children with 
ASD.  However, the Social Problems and Thought Problems subscales of the CBCL were only 
evaluated as fair at identifying children with ASD.  Previous researchers had demonstrated that 
the ASD-C had an overall correct classification rate of 91.3% (Matson, Gonzalez et al., 2009).  
However, the current study only included 14 children diagnosed with ASD.  Consequently, a 
larger sample would likely have resulted in improved diagnostic accuracy for the measure.  The 
ASD scale from the CBCL had previously been demonstrated to have sensitivities ranging from 
68% to 78% and specificities ranging from 73% to 92% (Ooi et al., 2011).  Thus, the current 
study replicates the validity of the ASD scale.  The Thought Problems subscale of the CBCL had 
been demonstrated to have sensitivities ranging from 82.9% to 94.3% and specificities ranging 
from 71% to 100% (Duarte, Bordin, de Oliveira, & Bird, 2003).  Mazefsky, Anderson, Conner, 
and Minshew (2011) likewise found that the Social Problems subscale of the CBCL significantly 
predicted ASD diagnosis.  Again, sample size likely contributed to the lesser findings in the 
current study.     
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Overall, the ASD scale of the CBCL and the ASD-C Diagnostic total were superior to the 
other subscales at identifying children diagnosed with ASD.  Both of these scales were 
determined to be good screeners for ASD in a sample consisting of typically developing children 
with psychological disorders, children with ASD, and controls.  An important implication of this 
study is that these measures accurately identified children with ASD while being economical, 
taking minimal administration time, and being quickly scored and interpreted by trained 
professionals with a master’s level degree in an associated field.  Poverty is a known risk factor 
for psychological disorders in children (Bringewatt & Gershoff, 2010; Knitzer, 1996;   et al., 
2007).  Thus, parent-report measures that can be easily administered to low SES families will 
hopefully lead to increased access to services. 
The current study also examined the diagnostic validity of the two measures for Anxiety 
Disorder.  The CBCL Anxious/Depressed subscale and Internalizing composite were both 
determined to be fair at correctly identifying individuals diagnosed with an Anxiety Disorder.  
Whereas, the Worry/Depressed subscale of the ASD-C failed to correctly classify children with 
Anxiety Disorder beyond chance.  For the purposes of this study and to account for the small 
sample size, anxiety disorders were lumped together into one overarching category.  Thus, 
children grouped in this category had diagnoses ranging from Specific Phobia to Panic Disorder.  
Especially in the case of specific phobia where the anxiety symptoms are highly particular, their 
symptom presentation might not map onto a scale that measures more general worry and anxiety.  
Future researchers with access to a larger sample should consider separating the anxiety 
disorders into different diagnostic categories to address the heterogeneity of the disorders. 
   Diagnostic accuracy for externalizing disorders was also considered in the current 
research.  The CBCL Attention Problems subscale was found to be poor at identifying children 
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diagnosed with ADHD, while the CBCL Externalizing composite failed to identify children with 
ADHD.  This is contrary to the findings of previous researchers, who found that the Attention 
Problems subscale significantly predicted ADHD (Hudziak, Copeland, Stanger, & Wadsworth, 
2004).  The failure of these subscales to accurately identify clinical inattention may be 
attributable to the heterogeneous nature of ADHD.  The clinical presentation of the disorder 
often shifts over an individual’s lifespan from overt hyperactivity in early childhood to persistent 
inattention in adolescence and adulthood (Biederman et al., 1996).  Additionally, the high rates 
of comorbidity between ASD and ADHD may have impacted the ability of the scale to 
differentiate between children with those disorders (Matson & Nebel-Schwalm, 2007b; Simonoff 
et al., 2008).  This was further complicated by the DSM-IV’s prohibition of diagnosing children 
with ADHD if they met criteria for ASD (Gargaro, Rinehart, Bradshaw, Tonge, & Sheppard, 
2011).  As there is neither an attention or hyperactivity subscale on the ASD-C, the measure was 
not evaluated for diagnostic accuracy for ADHD.   
As for identifying children diagnosed with ODD, the CBCL Rule-Breaking Behavior and 
Aggressive Behavior subscales were classified as good.  Hudziak and colleagues (2004) also 
found the Aggressive Behavior subscale to be accurate at identifying children with ODD.  
However, previous researchers had demonstrated that the Rule-Breaking Behavior subscale was 
only fair at distinguishing children with ODD from CD, but good at identifying children with CD 
in the general population (Ebesutani, Bernstein, Nakamura, Chorpita, Higa-McMillan, & Weisz, 
2010).  Surprisingly, the ASD-C Conduct subscale was only classified as fair and the ASD-C 
Tantrum Behavior subscale was classified as poor.  However, the Conduct subscale consists of 
only 4 items, and thus, may not have been able to accurately screen for all symptoms of ODD.  
Additionally, the Tantrum Behavior subscale included items that were likely endorsed by parents 
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of children with ASD as well as those with ODD.  ASD has been demonstrated to exacerbate 
externalizing symptoms and children with ASD exhibit high rates of tantrum behavior (Goldin, 
Matson, Tureck, Cervantes, & Jang, 2013; Tureck et al., 2013).  Future researchers should parse 
out which symptoms of the Tantrum Behavior subscale are more applicable to ODD and which 
are more generalized.  Additionally, the small number of children with each of the psychological 
disorders may have affected the findings.  In total, 24 children were diagnosed with an Anxiety 
Disorder, 24 children were diagnosed with ADHD, and 10 children were diagnosed with ODD. 
Future researchers should re-evaluate the diagnostic accuracy of these subscales with a larger 
sample.    
It is important to note that other factors may have influenced symptom ratings leading to 
potentially biased reporting.  Researchers have demonstrated that parent and child reports are 
typically discrepant with only low to moderate levels of agreement (De Los Reyes & Kazdin, 
2005; Grills & Ollendick, 2002).  This has been hypothesized to be due to an attribution bias, 
such that parents tend to report their children’s behavior differently if they feel that the behavior 
warrants treatment (De Los Reyes & Kazdin, 2005).  This highlights the impact of parent 
characteristics, including parental stress and psychopathology, on ratings (Smith, 2007).  Stokes, 
Pogge, Wecksell, and Zaccario (2011) found that parenting stress is the factor most consistently 
associated with overreporting.  This is especially important to consider when administering 
parent reports to children at risk for ASD, as Hayes and Watson (2013) found that parents of 
children with ASD experience significantly more stress than both parents of typically developing 
children and parents of children with other developmental disabilities (e.g., cerebral palsy and 
intellectual disability).  In instances where parents are suspected to be overreporting their 
children’s symptoms, the responsibility falls on the clinician to use direct observations to make 
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informed judgments about clinical diagnoses.  This is especially important when using the ASD-
C or CBCL as screening instruments, because neither of these two measures include a “lie scale.”                       
   Another possible limitation of the current study is that the CBCL and ASD-C have 
different labels for the response ratings.  The CBCL has parents rate each item as “not true,” 
“somewhat or sometimes true,” or “very true or often true.”  Whereas the ASD-C has parents rate 
each item as “not a problem or impairment,” “mild problem or impairment,” or “severe problem 
or impairment.”  How the ratings were worded could have impacted how parents interpreted the 
questions when responding.  Previous researchers have demonstrated that when the wording of 
the response is more familiar to the responder, he/she is more likely to endorse that item.  For 
example, Wiejters, Geuens, and Baumgartner (2013) found people were more likely to endorse 
“completely agree” than “strongly agree,” even though both ratings were expressing the same 
intensity of agreement.   
Another limitation related to the differential designs of the two measures is that the ASD-
C asks the extent an item was “ever” a problem on the diagnostic section and whether it was a 
“recent” problem on the comorbidity and problem behavior sections.  Conversely, the CBCL 
asks how the item describes your child “now or within the past 6 months.”  This difference in the 
timing of ratings is especially noteworthy, because many of the children undergoing evaluation 
were also receiving behavioral or pharmacological interventions that may have impacted the 
recent presentation of symptoms that were previously problematic.  The actual impact of 
wording was not examined in the current research due to the ongoing nature of data collection.  
Future researchers should administer each measure with both sets of responses in order to 
compare response styles. 
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  An additional implication of the current study is the importance of using valid measures 
of psychopathology when diagnosing children with developmental, behavioral, or affective 
disorders.  This is increasingly important as doctors frequently prescribe numerous psychotropic 
medications to children following minimal assessment of symptoms.  Olfson, Marcus, 
Weissman, and Jensen (2002) examined the difference in rates of psychotropic medication 
prescriptions among children and adolescents in the US in 1987 and 1996.  They found that 
medication use increased from 1.4 per 100 children in 1987 to 3.9 per 100 children in 1996.  This 
increase was largely attributed to more frequent prescription of stimulant medication to children 
between ages 6 and 14 years old.  These rates have continued to increase over the past two 
decades (Matson & Hess, 2011).  Negative side effects related to stimulants include insomnia, 
decreased appetite, headaches, and increased anxiety (Garcia, Logan, & Gonzalez-Heydrich, 
2012).  Thus, stimulant medications, such as methylphenidate, should be prescribed with caution 
and used only in instances when an ADHD diagnosis is confirmed by clinical testing and 
evaluation.         
 Furthermore, physicians frequently prescribe psychotropic medications including 
neurolepetics, antidepressants, antipsychotics, and stimulants to children with ASD (Mandell, 
Morales, Marcus, Stahmer, Doshi, & Polsky, 2008).  These medications are being prescribed 
despite a lack of evidence that they address any of the core symptoms of ASD (Matson & Hess, 
2011).  Rather, psychotropics are used to manage symptoms related to ASD including 
aggression, self-injurious behaviors, and repetitive behaviors (Hollander, Phillips, & Yeh, 2003).  
Mandell and colleagues (2008) found that 56% of children with ASD receiving benefits through 
Medicaid were prescribed at least one psychotropic medication and 20% were prescribed three or 
more medications concurrently.  This number may be a slightly high estimate for the general 
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population, as children who were uninsured or privately insured were found to be less likely to 
be prescribed three or more medications than those receiving Medicaid (Rosenberg, Mandell, 
Farmer, Law, Marvin, & Law, 2010).  Unfortunately, psychotropic medications are often used as 
the first line of treatment for children whose families are unable to afford early intensive 
behavioral interventions (EIBI), which are both time and cost prohibitive in many cases (Matson 
& Hess, 2011).  This leaves these individuals vulnerable to side effects ranging from irritability 
to weight gain to tardive dyskinesia (Campbell, Schopler, Cueva, & Hallin, 1996).  Future 
research should address the need for cost effective behavioral interventions for children with 
ASD.  This is especially relevant considering the increased availability and accuracy of low-cost 
diagnostic screens for children with ASD who are in need of treatment.   
This study made strides toward identifying stand-alone screening instruments for 
identifying ASD and psychological disorders in children with and without a possible 
developmental disability.  As previously discussed, there is significant controversy regarding the 
lack of available mental health services for children from low SES families (Bringewatt & 
Gershoff, 2010; Knitzer, 1996; McLearn et al., 2007).  Many of these children are being 
prescribed psychotropic medications for behavioral symptoms without receiving comprehensive 
psychological evaluations.  These medications are often unnecessary and result in adverse side 
effects (Matson & Hess, 2011).  The current study demonstrated that the ASD-C and the CBCL 
contain disorder-specific scales that accurately identified children with developmental, 
behavioral, and affective disorders.  The findings on the validity of the ASD-C are particularly 
important as the measure was developed specifically for an ASD population.  The three-part 
measure is easy to administer, score, and interpret by a trained clinician.  It could readily be 
utilized by pediatricians and other physicians who lack specific training in diagnosing ASD and 
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comorbid disorders (Meadows, Valleley, Haack, Thorson, & Evans, 2011).  Once a child was 
identified as being at risk for a psychological disorder, the physician would then refer the child to 
a psychologist or psychiatrist for additional assessment before any diagnostic determinations 
were made.  By screening more children in less time while maintaining good psychometric 
properties, the ASD-C and CBCL can identify children who would greatly benefit from 
behavioral treatments.  Early diagnosis and intervention predicts the best possible outcomes for 
these children, while allowing for the provision of necessary supports to their families (Barbaro 
& Dissanayake, 2009; Matson, Wilkins, & Gonzalez, 2008; Volkmar, Chawarska, & Klin, 2005).   
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APPENDIX B  
ASD Study Consent Form 
1. Study Title: Developing the Autism Spectrum Disorder (ASD) 
 
2. Performance Sites: Louisiana State University Psychological Services Center, preschools, 
grade schools, churches, hospitals or outpatient clinics, organizations, and internet websites.  
3. Contact:  Johnny L. Matson, Ph.D. (225) 578-8745 
4. Purpose of Study: Several diagnostic instruments exist that are designed to determine the 
presence of emotional difficulties and behavior problems in children and adults. Currently there 
are no screening instruments that incorporate differential diagnosis of the developmental 
disorders. The purpose of this study is to develop assessment instruments designed to examine 
the social skills, challenging behaviors, and symptoms of emotional difficulties in children, as 
well as autistic traits in adults.  
5. Participant Inclusion Criteria: Parents of children who are ≤ 18 years old receiving services 
at the Psychological Services Center; children who are receiving inpatient or outpatient 
medical/behavioral services, or currently attending preschools, grade schools, or church groups; 
children recruited via websites or organizations such as those for children with ASD or 
disabilities; and adults residing in the community. Exclusion Criteria: Parents, legal guardians, 
or informants unable or unwilling to provide informed consent or parental consent. Maximum 
number of subjects: 2000 
6. Study Procedures: Assessment instruments designed to examine the social skills, challenging 
behaviors, and symptoms of emotional difficulties in individuals will be administered to the 
sample of 2000 adult participants (i.e., parents of child participants). Participants will receive 
information about the study and given an opportunity to volunteer through informational mail-
outs at their child’s school, church, clinic, etc. or information given to them when calling about 
services at the Psychological Services Center. Once consent is granted, participants will be given 
assessment packets regarding the following either in person at the outpatient clinic, mail, or 
internet link. Participants will provide information regarding the individual’s: 1) demographics 
(e.g., age, gender, ethnicity, parents’ names, number of siblings, etc.); 2) current psychotropic 
drug use and diagnoses; 3) developmental milestones; 4) social skills (e.g., turns head towards 
caregiver, initiates verbal communication, complains often, prefers to be alone, disturbs others, 
interacts positively with others, etc.); 5) challenging behavior (e.g., circumstances in which the 
target behavior occurs); and 6) symptoms of other difficulties (e.g., tantrums, excessive worry or 
concern, initiates fights, fidgets or squirms excessively, stereotypies, intellectual disability, 
impaired social interactions, language delays, etc.). Participants who receive the packet via mail 
will receive a follow-up phone call to ensure that they have received the packet and have the 
opportunity to ask questions. This study will take approximately 1 hour to 1.5 hours for each 
participant. Additionally, children (recruited from the outpatient clinic) of a subset of the 
sampled adult participants (i.e., parents of child participants) will be administered an abbreviated 
assessment of intellectual functioning.  
7. Benefits: Participants under the age of 18 years may benefit from this study by taking 
advantage of reduced price assessment services at the Psychological Services Center in Baton 
Rouge, Louisiana. If parents decide to take advantage of this offered benefit, participants will be 
required to come into the clinic to complete a parent interview and child observation session. All 
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treatment services will be full price. Further, participants may benefit form professionals 
developing more reliable and valid assessment measures, suggesting improved diagnostic 
capabilities and more effective treatment interventions.  
8. Risks/Discomforts: There is a small possibility of disclosure of personal information 
associated with this study. There are no other known risks resulting from participating in this 
study. Risks experienced should be those limited to those commonly experienced when receiving 
services from a public mental health clinic.  
9. Measures taken to reduce risk: All participants will be given participant numbers. All data 
collected will be stored in reference to this number only. There will be one (1) master list which 
will list patient number by participant number to provide a means by which participants can 
choose to remove their data from the data set after participation. This list will be the only means 
by which data collected can be linked to personal information such as name or patient number. 
This list will be stored in a locked file cabinet, separately from the data collected.  
10. Right to refuse: Participation is voluntary. Participants may change their mind and withdraw 
from the study at any time before the conclusion of the study without penalty or loss of any 
benefit to which they may otherwise be entitled.  
11. Privacy: This study is confidential. Data will be kept confidential unless release is legally 
compelled.  
12. Financial information: There is no cost to the participant and no payment will be provided 
for participation.  
13. Withdrawal: There are no consequences for terminating participation in this study, which 
will last approximately 1 hour and 30 minutes in duration for each participant. To withdraw from 
the study, participants must inform the principle investigator of their desire to do so before the 
end of the study.  
14. Removal: A participant’s data may be removed from the study if it is discovered that there 
were errors in administration of any measure for that particular participant.  
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